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Abbreviations 
 
ATPase    Adenosine triphosphatase activity 
ARDS     Acute respiratory distress syndrome  
Ach     Acetylcholine 
[Ca]i       Intracellular calcium concentration 
CSA     Cross-sectional area 
COPD    Chronic obstructive pulmonary disease 
cGMP    Cyclic guanosine monophosphate  
ECC    Excitation-contraction coupling 
EDL    Extensor digitorum longus   
eNOS    Endothelial NOS  
EPO    Erythropoietin 
FRC    Function residual capacity 
H2O2     Hydrogen peroxide 
HIF    Hypoxia inducible factor 
L-NMMA    NG-Monomethyl-L-arginine  
L-NNA   Nω-nitro-L-arginine 
L0     Optimal muscle bundle length  
MDA     Malondialdehyde 
NOS    Nitric oxide synthase 
NTF    Neuromuscular transmission failure  
NMJ    Neuromuscular junction  
nNOS            neuronal NOS 
ONOO-    Peroxynitrite  
O2● -     Superoxide anions  
OD    Optical density 
Pt     Maximal twitch force   
Po      Maximal tetanic force  
RyR     Ryanodine receptor 
ROS     Reactive oxygen species 
RNS       Reactive nitrogen species  
Sp-NO    Spermine NONOate     
SR      Sarcoplasmic reticulum  
SOD    Superoxide dismutase  
SNP    Sodium nitroprusside 
SNAC    S-nitroso-N-acetylcysteine  
TBA    Thiobarbituric acid 
VGEF    Vascular endothelial growth factor 
Vmax     Maximal shortening velocity  
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Introduction 
Hypoxia is a common feature in several respiratory diseases including chronic 
obstructive pulmonary disease (COPD), severe pneumonia and acute respiratory 
distress syndrome (ARDS). Diaphragm force generation is impaired and fatigability is 
increased under hypoxic conditions both in vitro and in vivo (69; 10; 31; 34). 
Impaired force generation of the respiratory muscles may result in ventilatory failure. 
Therefore, understanding mechanisms of hypoxia-induced respiratory muscle 
dysfunction are of major clinical importance.  
It is well established that reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) play a prominent role in modulation of force in skeletal muscle under 
hyperoxic conditions (4; 5; 38; 57). Recent data indicate that ROS modulate force 
generation in cardiac and skeletal muscle under hypoxic conditions (16; 31; 48). 
Therefore, in the present thesis the role of free radicals, especially nitric oxide, in 
respiratory muscle function under hypoxic conditions was assessed.  
 
The Diaphragm 
The diaphragm and accessory muscles of respiration are morphologically and 
functionally skeletal muscles. These muscles are the only skeletal muscles that 
contract with regular rhythm throughout life. Dysfunction of the respiratory muscles 
is of clinical importance since reduced respiratory muscle function may contribute to 
the sensation of dyspnea, reduced exercise capacity, alveolar hypoventilation during 
exercise, nocturnal desaturation, hypercapnia and prolonged weaning from 
mechanical ventilation. Surprisingly, relatively little is known about adaptations of the 
diaphragm in chronic respiratory disorders. In patients with COPD (FEV1 33 ± 4% 
pred) a higher proportion of type I (slow) fibers and a lower proportion of type II 
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(fast) fibers have been found in the diaphragm compared to healthy subjects (41; 42). 
Moreover, it has been shown that in patients with COPD a strong correlation exists 
between function residual capacity (FRC) and proportion of slow myosin heavy chain 
fibers in the diaphragm (46). Recent data from our laboratory show that in the 
diaphragm of patients with mild / moderate COPD (GOLD I/II), force generation of 
single fibers is reduced, accompanied by reduced myosin heavy chain content (54). 
These data clearly demonstrate the plasticity of diaphragm morphology and function 
in chronic respiratory diseases. Currently, we do not know the stimulus that induce 
these modification, but systemic inflammation may be at play (3). It has been 
suggested that causative factors for respiratory muscle dysfunction in COPD include 
electrolyte disturbances (8), hypercapnia (36), forward failure (33) and prolonged use 
of corticosteroids (14). In addition, the altered geometry of the thorax in severe 
emphysema compromises the ventilatory pump function of the diaphragm (13). 
Malnutrition, which frequently occurs in moderate / severe COPD may also play a 
role. The role of hypoxia in respiratory muscle function is incompletely understood.  
 
Hypoxia in Skeletal Muscle and Respiratory Muscle 
Respiring organisms rely on mitochondrial oxidative phosphorylation for the 
generation of ATP. O2 consumption is regulated in accordance with tissue metabolic 
activity, as long as the availability of O2 is sufficient to maintain ATP production at a 
level that matches cellular energy needs. When the supply of oxygen to the 
mitochondria falls below a critical low level, O2 utilization becomes limited by O2 
availability and diaphragm muscle then depend on anaerobic pathway (18; 58). This 
results in several changes in the intracellular milieu. For instance, experiments in 
skeletal muscle have show that muscles release substantial amounts of lactic acid 
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when stimulated during severe hypoxia (47). Lactic acid accumulation, in turn, results 
in an increase in intramuscular hydrogen ion concentrations. High hydrogen ion 
concentrations inhibits sarcoplasmic reticulum function and reduce the binding of 
calcium to the contractile protein complex during muscle excitation, consequently 
impairing muscle function (22). A similar relationship has been documented between 
Po2 and metabolites ATP/ADP and phosphocreatine (12; 26). However, in isolated 
cells, O2 supply-limited metabolism does not begin until extracellular Po2 falls to less 
than 5-6 mmHg (0.7 – 0.8 kPa). This is consistent with measurements indicating that 
the apparent Km for O2 at cytochrome oxidase is < 1uM. When tissue oxygen uptake 
becomes O2 supply limited, cells are liable to sustain ischemic injury resulting from 
ATP depletion, mitochondrial depolarization, and activation of cell death pathways. 
Multicellular organisms have evolved a complex set of adaptive responses to prevent 
the onset of O2 limited metabolism, and all respiring organisms have evolved distinct 
molecular responses to lessen the consequences of cellular O2 deprivation. By their 
nature, these protective responses are anticipating and require a cellular O2 sensor to 
trigger their activation during mild hypoxia, before a lethal condition has been 
reached. For example at the organism level increases in alveolar ventilation are 
triggered by the carotid and aortic bodies, increases in circulating erythrocyte mass 
are triggered by the secretion of erythropoietin (EPO), and increases in capillary 
density are initiated by the release of vascular endothelial growth factor (VGEF) from 
hypoxic cells. At the molecular level, activation of hypoxia inducible factor (HIF) 
leads to the increased transcriptional expression of genes encoding transcription 
factors that regulate other genes.  
How hypoxia impairs force generation of skeletal muscles is largely unknown. 
Hypoxia has been shown to induce ultra-structural damage in mouse soleus- and 
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diaphragm muscle. Contraction damage comprised of blurred and dissoluted Z-lines, 
and dissolution of I-bands. Relaxation damage included dissolution of sarcomeres, 
and early spacing of myofibrils. Other signs of ultrastuctural damage, such as 
disruption of the plasma membrane, mitochondrial swelling and myofibrillar 
breakdown have also been described in hypoxic muscle (53). Hypoxia has also been 
shown to inhibit sarcolemma reticulum Ca2+  re-uptake from the intracellular space 
(15; 75). This could result in an increase of intracellular Ca2+ levels, what could 
destroy sarcolemma and cytoskeleton, via activation of Ca2+ dependent proteases.  
It has been suggested that reduction in force occurs well before depletion of 
high-energy phosphates, for instance by mechanisms described above. This may be a 
physiological mechanism to prevent muscle damage. Studies by Schumacker and also 
other groups have shown that hypoxia markedly increases intracellular ROS 
generation in smooth muscle and cardiac myocytes (16; 66; 70), which can adversely 
affect muscle performance. Moreover, hypoxia is found to be associated with 
reduction in antioxidant enzyme activity (45), consequently muscle tissue will be 
more vulnerable to the effects of ROS. Mohanraj et al demonstrated protective effects 
of a variety of antioxidants i.e., superoxide scavenger Tiron against hypoxia-induced 
impairment in force generation of the rat diaphragm in vitro (48). Studies from our lab 
show that antioxidants such as N-Acetylcysteine and Tiron reduce in vitro fatigability 
of the rat diaphragm under hypoxic conditions (31).  
 
Nitric Oxide: Biochemistry and Physiology 
NO is a colorless gas that is soluble in water, but 6-8 times more soluble in lipids. 
Thus, it can easily diffuse in and out of cells. NO has an unpaired electron and is 
therefore a free radical. NO is synthesized from L-arginine by NO synthase (NOS). 
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There are three isoforms, neuronal-, inducible- and endothelial NOS (49). The direct 
effects of NO occur very close to its site of production (43). However, NO and/or 
related molecules can interact with a wide range of targets, permitting NO to have 
paracrine and endocrine effects (6). Molecular targets in skeletal muscle for NO fall 
into three general categories (see Fig. 1). First, NO can react with superoxide anions 
(O2● -) and molecular oxygen to generate NO derivatives (NOx), which retain redox 
activity and participate in electron transfer reactions (64). The reaction with O2- 
generates peroxynitrite, a highly reactive free-radical species and a mediator of 
oxidative injury of cellular components (11). Second, reaction with transition metals, 
such as haem or iron-sulphur centers to form NO-metal adducts. This mechanism 
allows NO to modulate enzyme activity (63). For instance, in skeletal muscle, NO-
haem binding stimulates the activity of soluble guanylyl cyclase and increase the level 
of cyclic guanosine monophosphate (cGMP) (38). Finally, NO reacts with reduced 
protein thiol groups (RSH or RS) via S-nitrosylation to form RS-NO groups. 
Nitrosylation of thiols or thiol proteins provides a mechanism by which NO can be 
transported in a stable form (63). The main target sites for NO within the cell are 
metal- and thiol-containing proteins and lower molecular weight thiols (63). NO can 
either act as a physiological messenger or as a cytotoxic agent (43). Its final function 
may be determined by a specific combination of factors, such as the rate of NO 
production, timing, localization of NO release and the relevant targets likely to be 
affected (43).  
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Fig. 1:  Basic signaling pathways of NO in skeletal muscle.  
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Nitric Oxide in Skeletal Muscle 
Skeletal muscle is a major source for NO in the body (52). Under physiological 
conditions, both nNOS and eNOS isoforms are responsible for NO synthesis in 
skeletal muscle. Generally, higher activities are measured in fast-twitch muscles than 
in slow twitch. This reflects distribution of nNOS, which is most evident in the 
sarcolemma of fast-twitch fibers shown by immuunohistochemical staining and is 
associated with the dystrophin complex in rodents (38). nNOS is also localized in the 
post-synaptic surface of mammalian neuromuscular junction of both fast- and slow-
twitch fibers (40). The eNOS isoform is expressed by all skeletal muscle fibers, where 
it associates with mitochondrial, and vascular endothelium (39). The fiber-type 
distribution is different in humans. Frandsen et al. found that nNOS was located in the 
sarcolemma and cytoplasm of all muscle fibers but showed a greater expression in 
type I muscle fibers. The localization of nNOS was particularly nearby the 
mitochondrial and sarcolemma. eNOS is found in microvascular endothelium and the 
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endothelium of larger vessels (21) and has a substantial role in blood pressure control. 
Both nNOS and eNOS activity are dependent on intracellular Ca2+ levels (20; 56). 
The iNOS isoform is not expressed under physiological conditions in muscle fibers, 
but is widely distributed throughout the immune cells including macrophages and 
glial cells. This isoform has been shown to be stimulated by inflammatory cytokines 
(72). iNOS has been shown to be markedly increased in peripheral skeletal muscle of 
patients with chronic heart failure, as determined by Northern blot or RT-PCR 
analysis (28).   
Mechanical activity influences NO production in skeletal muscle by regulating 
NOS activity in the short term (23; 61) and regulating protein expression of nNOS 
and eNOS in the longer-term (9; 65; 67). Studies on the effects of an acute increase in 
muscle activation on muscle NOS activity are complex. For instance, NOS activity 
has been shown to increase in limb skeletal muscle activation, but NOS activity was 
reduced after resistive loading in respiratory muscles (23; 61). Chronic (8 wk) 
treadmill exercise has been shown to cause a fourfold increase in nNOS expression 
and a twofold increase in eNOS expression in rat soleus muscle (9). Three to four 
weeks swim training in rats enhanced quadriceps muscle NOS activity and nNOS 
protein expression (65). Artificial limb muscle stimulation (3-4 weeks) resulted in a 
significant elevated muscle NOS activity and concomitant augmentation of muscle 
nNOS gene expression (60). Similarly, Vassilakopoulos et al (67) showed that chronic 
whole body exercise training in rats elicited significant upregulation in NOS activity, 
and both nNOS and eNOS protein expression of limb and diaphragm muscles. No 
detectable iNOS protein expression was found in any of the muscle samples (67). The 
different response for NOS expression and activity in these studies probably reflect 
differences in species, muscle type studied and especially muscle activation paradigm. 
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Nevertheless, these studies strongly support the notion that NO may be involved in 
mechano-sensing in skeletal muscle fibers. Indeed, recently it was shown that NO 
production is an important component of the signaling pathway that is responsible for 
adult skeletal muscle adaptation to mechanical overload (62). 
Enhanced muscle NO production in exercise-trained rats may influence many 
(patho)-physiological mechanisms in skeletal muscle fibers. Elevated nNOS and 
eNOS expression in response to exercise training represents an adaptive response by 
muscle fibers to cope with increased demands for glucose uptake (9). Moreover, 
endogenous NO production serves as an antioxidant by directly scavenging oxygen 
radicals and by modifying the influence of oxygen radicals on excitation-contraction 
coupling (2). Finally, enhanced NO production in trained muscles is expected to 
improve muscle perfusion by inducing direct relaxation of vascular smooth muscles.  
Several studies have been published on the effects of NO modulation on 
skeletal muscle contractility in isolated muscle preparation. The overall effect 
depends on the experimental paradigm. Kobzik et al (38) have shown that incubating 
rat diaphragm muscle strips with NOS inhibitors or NO scavengers, increase 
submaximal force generation and shift the force-frequency relationship leftwards. NO 
donors reversed the effects of NOS blockade (1; 38; 59). Such inhibition of 
contractility by NO has been confirmed in rat diaphragm (1), in both neonatal- and 
adult rat diaphragm (17), in an isolated mouse Soleus preparation (51), in guinea pig 
diaphragm and gastrocnemius muscle (25). Apart from the inhibitory effect on 
excitation–contraction coupling, NO donors slowed the decline of maximal force in 
mouse soleus muscle in fatiguing contractions (51), suggesting that NO could 
preserve skeletal muscle function in vitro during strenuous contraction. In contrast to 
the depression of isometric force generation at submaximal stimulation frequency, 
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during loaded shortening, skeletal muscle may require endogenous NO to achieve 
optimal velocity and power output. NOS inhibitors slow shortening velocity and 
power generation of the rat diaphragm, whereas NO donors reverse this effect (50).  
The mechanisms by which NO mediates its effect on contractile properties 
remain unclear. In contrast to smooth muscle, the magnitude of cGMP-mediated 
changes is limited in skeletal muscle (56). NO may act directly on modulating 
regulatory proteins via redox effects (56). Thiol groups of the Ca2+ release channels of 
the SR are likely sites for such interaction (2; 32). NO effects appear to be 
concentration dependent. Low concentrations of NO prevent channel opening from 
oxidation-induced activation, in this way reducing the rate of Ca2+ release. High 
concentrations promote opening of the RYR1 channels (2). The effect of NO on the 
thiol groups of RYR1 could also be depended on local Po2 as well (19). A second 
potential target is the SR calcium-dependent ATPase (SERCA), an enzymatic pump 
that scavenges calcium from the cytosol (37). Exposure of elevated NO levels also 
inhibits SERCA via thiol oxidation (68). Another proposed mechanism by which NO 
might affect contractility is a reduction in Ca2+ sensitivity of force generation (5; 30). 
In addition, reactive thiols present on the myosin head may also participate in NO 
modulation of excitation-contractions coupling (55).       
 
Skeletal Muscle Hypoxia: Role for Nitric Oxide 
Molecular oxygen is an essential substrate for NO synthesis by NOS (44). O2 
substrate limitation may regulate NO production under hypoxic conditions. Numerous 
investigators have examined the effects of hypoxia on NO production in a variety of 
tissues and cells such as perfused lungs, pulmonary endothelial cells, bovine aortic 
endothelial cells and coronary microcirculation (7; 27; 29; 71; 74). 
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 Little is known about the effects of hypoxia on skeletal muscle NO 
generation. Chronic (60 days) of hypobaric hypoxia elicited approximately two- and 
nine fold increase in diaphragmatic eNOS and nNOS protein expression respectively, 
and about a 50% rise in diaphragmatic NOS activity. In contrast, NOS activity and the 
expression of these proteins declined significantly in response to 9 months of hypoxia 
(35). The underlying mechanism by which hypoxia modulates NOS expression / 
activity in unknown.  
For all isoforms of NOS, L-arginine, NADPH and O2 are co-substrates for 
synthesizing NO. It is generally accepted that concentration of L-arginine and 
NADPH are so high in tissues that they are unlikely to be a limiting factor in NO 
generation (44). The low level of O2 during hypoxia may reduce NO synthesis in the 
catalytic pathway, but it may not be the dominant factor in vivo (24; 74). Moreover, 
e/nNOS are calcium/calmodulin-dependent enzymes and the concentration of calcium 
is increased under hypoxic conditions. Intracellular calcium concentrations may be 
increased sufficiently during hypoxia and serve as a seconded message to activate NO 
synthesis (29; 73). Surprisingly, the effects of NO modulation on skeletal muscle 
force generation under hypoxic conditions have not been studied.  
 
Outline of Thesis 
This thesis will focus on the role of NO in rat diaphragm contractility under acute 
hypoxic conditions. Numerous investigators have shown expression of NOS in 
skeletal- and respiratory muscle. Insight is emerging in the role of NO in excitation 
contraction coupling, and glucose metabolism. However, the role of NO in hypoxic 
respiratory muscle contraction has not been studied. In the present studies we aimed 
to investigate the effects of NO modulation on hypoxic skeletal muscle function in 
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vitro. In addition, we assessed the role of NO on rat diaphragm neurotransmission 
under acute hypoxic conditions in vitro.  
Chapter 2 describes the effect of NOS inhibition, NO scavenging and NO donors on 
isometric contractile properties of the rat diaphragm muscle bundles under hypoxic 
(Po2 ~ 7.0 kPa) conditions. Since the effects of NO modulation on skeletal muscle 
contractility have not been studied previously, dose – response curves for NOS 
inhibition on twitch and tetanic force were determined.  
 In chapter 3, the effects the effects of NOS inhibition, NO scavenging and 
NO donor on rat diaphragm muscle bundle isotonic contractile properties were 
assessed under acute hypoxic conditions. In addition, the effects of NO modulation on 
isotonic fatigability of rat diaphragm muscle bundles were determined during acute 
hypoxia.  
Hypoxia may enhance generation of both NO and superoxide in skeletal muscle, 
resulting in the formation of peroxynitrite. In chapter 4, the effects of acute hypoxia 
on rat diaphragm peroxynitrite formation were determined. In addition, the role of 
peroxynitrite in diaphragm contractility was assessed under acute hypoxic conditions. 
It is well known for many years that hypoxia affects neuromuscular transmission in 
the diaphragm. In Chapter 5, we investigated the role for NO in rat diaphragm 
neuromuscular transmission under acute hypoxic conditions. Neurotransmission was 
determined by measuring force generation through direct muscle stimulation and by 
stimulation via the phrenic nerve.  
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Abstract 
Hypoxia disturbs the Ca2+ regulation and increases the intracellular Ca2+ 
concentration ([Ca2+]i), which may in turn activate nitric oxide (NO) synthase 
regulated by [Ca2+]i. Since NO reduces the isometric contractility of rat diaphragm in 
vitro, we hypothesize that NO contributes to impaired force generation of hypoxic 
diaphragm. The effects of different concentrations of the NOS inhibitor, NG-
Monomethyl-L-arginine (L-NMMA), the NO scavenger hemoglobin (150 µM) and 
the NO donor Spermine NONOate (Sp-NO; 1 mM) were determined on isometric 
contractility during hypoxia (Po2 ~ 7 kPa (~ 54 mmHg)) and hyperoxia (Po2 ~ 83 kPa 
(~ 639 mmHg)). Hypoxia significantly reduced maximal twitch tension (Pt), and 
submaximal tetanic tension (30 Hz, P30) in all L-NMMA groups. Low concentration 
of L-NMMA (30 μM) increased P30 but high concentration of L-NMMA (1000 μM) 
reduced P30 during hypoxia. The effects of L-NMMA on force generation were more 
pronounced during hypoxia compared to hyperoxia. Peak increases in P30 and Pt were 
observed with a concentration of 30 μM L-NMMA during hypoxia, but with 10 μM 
L-NMMA during hyperoxia. The same concentration of hemoglobin increased P30 
and Pt less during hypoxia compared to hyperoxia. Sp-NO reduced Pt, P30 and 
maximal tetanic tension (Po) during hypoxia; these effects were abolished in the 
presence of hemoglobin. Sp-NO did not alter Pt, P30 and Po during hyperoxia. We 
conclude that NO plays a more prominent role during hypoxia and that NO 
contributes to the depression of force generation of hypoxic rat diaphragm in vitro. 
This change may be related to elevated NO generation within the hypoxic diaphragm.  
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Introduction  
 
Growing evidence indicates that nitric oxide (NO) plays an important role in the 
physiology of skeletal muscle (19; 23; 34). Skeletal muscle, including the diaphragm 
of various species, continually produces NO (2; 4; 23). NO is produced in biological 
systems via the enzymatic action of NO synthase (NOS) (27). The constitutive NOS 
isoforms (neuronal NOS (nNOS) and endothelial NOS (eNOS)) are calcium-
dependent; i.e. the activity of these isoforms is tightly linked to intracellular Ca2+ 
levels (14; 38). Skeletal muscle produces NO at low rates under resting conditions 
while NO production is enhanced during muscle activity (4). 
It has been shown that NO modulates in vitro force generation of skeletal 
muscle (23; 25; 39). NOS inhibitors increase maximal twitch and submaximal tetanic 
force and shift the force–frequency relationship of rat diaphragm upward and to the 
left. These alterations are reversed by NO donors, indicating that NO impairs 
excitation-contraction coupling (ECC) in unfatigued muscle.   
Dysfunction of the respiratory muscle, especially the diaphragm, frequently 
occurs in patients with severe chronic obstructive pulmonary disease (COPD). 
Hypoxia, which is a common feature in severe COPD, impairs the force generation of 
rat diaphragm in vitro and in vivo (5; 18). The precise mechanisms, however, are still 
unknown. Elevated contractile activity of the diaphragm in COPD may enhance NO 
generation (9; 40). Moreover, recent data suggest that NO might influence the 
development of contractile dysfunction during hypoxia. Firstly, biological activities of 
NO and reactive oxygen species (ROS) are strongly inter-dependent (1; 25), and data 
from our laboratory recently showed that antioxidants reduced the hypoxia-induced 
rat diaphragm force generation in vitro (18). Secondly, NO plays a role in hypoxia / 
reoxygenation injury of the cardiac myocyte  in vivo (11). To the best of our 
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knowledge no previous study has examined the effects of NO on skeletal muscle 
function during hypoxia.  
 Hypoxia impairs the sarcoplasmic reticulum (SR) Ca2+ re-uptake from the 
intracellular space (10; 45). This could result in an increase of [Ca2+]i levels, which, in 
turn, may potentiate NO production (16). Based on previous studies showing that NO 
depresses the force generation of the rat diaphragm during normoxia (23; 39),  we 
hypothesized that NO contributes to the impaired force generation of hypoxic 
diaphragm. If this is correct, then the inhibition of endogenous NO production will 
increase in vitro force generation of rat diaphragm while supplementation of 
exogenous NO will accelerate the hypoxia-induced force reduction of rat diaphragm 
during hypoxia. 
Accordingly, the aim of the present study was to investigate the effects of 
different concentrations of the NOS inhibitor NG-Monomethyl-L-arginine (L-
NMMA), the NO scavenger hemoglobin and the NO donor Spermine NONOate (Sp-
NO) on rat diaphragm force generation during severe hypoxia in vitro and to compare 
these effects to hyperoxic conditions.  
 
 
Methods 
Study design 
The role of NO in isometric contractile properties of the rat diaphragm in vitro was 
assessed during hypoxia. Accordingly, the effects of different concentrations of the 
NOS inhibitor L-NMMA and the NO scavenger hemoglobin were evaluated on rat 
diaphragm force generation either during standard in vitro conditions (hyperoxia) or 
during severe hypoxia. The effects of  the NO donor Sp-NO on force generation were 
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also tested in same experimental conditions. The local Animal Ethics Committee 
approved the study.  
 
General procedures 
Adult male outbreed Wistar rats, aged 16-18 wk and with mean body weight of 324 ± 
12 (SE) g were used. The animals were housed in a specific pathogen-free unit and 
fed ad libitum. The rats were anesthetized with pentobarbital sodium (70 mg/kg body 
wt ip). Diaphragm bundles were prepared as previous described (18; 43). Briefly, a 
tracheotomy was performed, and a polyethylene cannula was inserted. The animals 
were mechanically ventilated with 100% oxygen. The diaphragm and adherent lower 
ribs were quickly excised after a combined laparotomy and thoracotomy, and were 
immediately submersed in cooled oxygenated (95% O2-5% CO2) Krebs solution at pH 
~ 7.4. This Krebs solution consisted of 137 mM NaCl, 4 mM KCl, 2 mM CaCl2, 1 mM 
MgCl2, 1 mM KH2PO4, 24 mM NaHCO3, and 7 mM glucose and 25 μM d-tubocurarine 
(Sigma, Bornem, Belgium). From the central costal region of the right and left 
hemidiaphragm, one rectangular strip (~ 2.5 mm wide) was dissected parallel to the long 
axis of the muscle fibers. Silk sutures were tied firmly to both ends.  
 
Contractile Measurements 
The strips were mounted vertically in separate tissue baths containing Krebs solution, 
maintained at 26 °C, and perfused with a 95% O2-5% CO2 mixture. The origin of the 
muscle was tied to a glass hook fixed to the bottom of the tissue bath. The central 
tendon end was attached to an isometric force transducer (Sensotec, model 31/1437-
10, Columbus, OH, USA) mounted on a micrometer. The muscle was stimulated 
directly by using platinum plate electrodes placed in close apposition to either side of 
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the muscle. Stimuli were applied with pulse duration of 0.2 ms and train duration of 
400 ms and were delivered by a stimulator (ID-Electronics, University of Nijmegen, 
The Netherlands) activated by a personal computer. Data acquisition and storage of 
the amplified signal were performed with a Dash-1602 interface on a personal 
computer (Twist-trigger software, ID-Electronics). Muscle preload force was adjusted 
with the micromanipulator until optimal fiber length (L0) for maximal twitch force 
(Pt) was achieved. Baseline twitch force (Pt), submaximal tetanic force (P30, 30 Hz 
stimulation frequency in 250 ms duration train) and maximal tetanic force (Po, 100 Hz 
stimulation frequency in 250 ms duration train) were determined after 15 minutes of 
thermo-equilibration during hyperoxia. 
 
Experimental protocols 
Protocol 1: Dose-dependent effects of L-NMMA during both hypoxia and hyperoxia. 
The effects of different concentrations of L-NMMA (NG –Me-L-Arg, AcOH, 
Calbiochem, Breda, The Netherlands) on isometric contractility during hypoxia were 
compared with contractility in standard Krebs solution during hypoxia. To assess the 
effects of hypoxia on rat diaphragm contractility similar measurements were 
performed during hyperoxic conditions. Accordingly, thirteen experimental groups 
were studied in protocol 1: hypoxia: control, 1 µM, 10 µM, 30 µM, 100 µM, 200 µM, 
300 µM, 1000 µM L-NMMA; hyperoxia: control, 1 µM, 10 µM, 30 µM and 100 µM 
L-NMMA. The diaphragm bundles were randomly allocated to the treatment groups. 
Immediately following baseline contractile measurements (Pt and P30), the perfusion 
of tissue bath was either maintained with hyperoxia (95% O2 and 5% CO2) or 
switched to hypoxia (95% N2 and 5% CO2). Diaphragm bundles were exposed to 
different concentrations of L-NMMA. In the present in vitro experimental set-up 
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incubation time of 90 min was used to ensure that L-NMMA inhibits NO generation 
sufficiently, and infrequent simulations were conducted to make preparations stable. It 
has been found that submaximal force is more sensitive to NOS inhibitors (3; 23). A 
pilot study (not shown) showed that the L-NMMA decreased P30 over a period of 
ninety minutes, however it had little effect on Po with the result that the contractile 
measurements on the L-NMMA group were only observed at Pt and P30. After 
incubation with L-NMMA, Pt and P30 were measured again in diaphragm muscle 
bundles. 
Protocol 2: Contractile effects of Hemoglobin and Sp-NO. To ascertain that the 
effects of L-NMMA on isometric contractile properties were mediated by endogenous 
NO, similar experiments were conducted with the NO scavenger hemoglobin (Bovine, 
Sigma Chemical, Zwijndrecht, the Netherlands). After baseline contractile 
measurements (Pt, P30 and Po), the gas mixture was either maintained on hyperoxia or 
switched to hypoxia. At same time the bathing medium was changed to the Krebs 
solution containing 150 µM hemoglobin (23). Since in a pilot study the increase in 
force generation were observed at 30 min following hemoglobin administration 
during both hypoxic and hyperoxic conditions, an incubation time of 30 min was 
used. After hemoglobin equilibration Pt, P30 and Po were measured. 
To determine if the contractile properties were also sensitive to exogenous NO 
during hypoxia the effects of Sp-NO ([N - (2-Aminoethyl)- N - (2-hydroxy-2-
nitrosohydrazino) -1, 2-ethylenediamine; NOC-22]; Calbiochem, Breda, The 
Netherlands) were tested. After the measurements of baseline Pt, P30 and Po, the 
perfusion of tissue bath was maintained or changed to the conditions as described 
above. Sp-NO (1 mM) was added directly to the physiological saline solution in the 
tissue bath (26ºC) (41). Although it is not known in what magnitude Sp-NO 
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supplementation alters NO in striated muscle, this concentration has been shown to 
reduce force generation in permeabilized rabbit psoas muscle fibers at 15ºC (17). 
The Sp-NO was prepared fresh for each experiment. Since some NO donors 
are sensitive to light, the experiments were conducted in a darkened laboratory (33). 
Both at 10 minutes and 30 minutes Pt, P30 and Po were measured after addition of Sp-
NO. These time points were chosen because Sp-NO releases NO with a half-life of ~ 
40 min (31). 
To verify that NO was the mediator of changes in force generation by Sp-NO, 
150 µM hemoglobin was used in similar experimental protocols to scavenge NO in 
the presence of Sp-NO (23). In addition, a potential issue with the use of NO donors is 
whether the observed effects are mediated via NO or via degradation products. We 
therefore conducted experiments using degraded Sp-NO (17). Degraded Sp-NO was 
used in similar experimental protocols as described above. Accordingly, in the 
hyperoxic group four treatment regimens were studied: control for Sp-NO, Sp-NO; 
control for hemoglobin and hemoglobin. In the hypoxic group six  treatment regimens  
were investigated: control for Sp-NO, Sp-NO, Sp-NO plus hemoglobin, degraded Sp-
NO; control for hemoglobin and hemoglobin.  
At the end of the protocols pH, Po2, and Pco2 of the Krebs solution in the 
tissue baths were measured. Subsequently, the length and dry-weight of each 
diaphragm strip were measured. Cross-sectional area (CSA) was calculated by 
dividing diaphragm strip weight (g) by strip length (cm) times specific density. 
 
Statistical Analyses 
All data are presented as mean ± standard error (SE). Comparisons of measurements 
made on a single parameter (e.g., submaximal force generation, P30) between two or 
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more experimental groups were made using one-way ANOVA, with post hoc testing 
(Student-Newman-Keuls) to determine statistical differences between individual groups. 
Comparisons of contractile parameters between the two treatment groups were analyzed 
using repeated-measures ANOVA.  Statistical analysis was performed using the SPSS 
package, v 9.0 (Chicago, IL). Comparisons were considered significant at p < 0.05.  
 
Results 
Verification of tissue bath hypoxia and strip dimensions 
Perfusion of the tissue baths with the hypoxic gas mixture significantly reduced Po2 in 
the Krebs solution to 7.1 ± 0.3 kPa (~ 54 mmHg), as compared with 83.4 ± 0.9 kPa 
(639 mmHg) in the hyperoxia group (p < 0.001). pH was 7.39 ± 0.01 in hypoxic 
groups and 7.42 ± 0.01 in hyperoxic groups (P > 0.05); Pco2 was not significantly 
different between hypoxia and hyperoxia groups (4.8 ± 0.1 (~ 37 mmHg) and 4.6 ± 
0.2 kPa (~ 34 mmHg), respectively, P > 0.05). Diaphragm muscle strip dimensions 
were not significantly different between experimental groups (P > 0.05 by one-way 
ANOVA). Average muscle strip weight was 31.4 ± 1.1 mg, and strip length at Lo was 
19.2 ± 0.9 mm. 
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Figure. 1.  Dose-dependence of L-NMMA effects on force generation of rat diaphragm during 
hypoxia (Po2 ~ 7.1 kPa) and hyperoxia (Po2 ~ 83 kPa).  
A: Submaximal tetanic tension (P30). B: Twitch tension (Pt). Values are means ± SE expressed as 
percentage of initial values. P30 and Pt are shown after 90 min incubation with 0-1000 µM L-NMMA in 
hypoxia and 0-100 µM L-NMMA in hyperoxic groups. L-NMMA with 30 μM concentration 
significantly increased P30 during hypoxia while  L-NMMA with 10 μM increased P30 during hyperoxia 
(n = 7 bundles). 1000 µM L-NMMA significantly reduced P30. The effects of L-NMMA on Pt in all of 
test groups were not statistically significant during hypoxia and during hyperoxia (P = 0.41 at 30μM L-
NMMA in hypoxia and P = 0.35 at 10 μM in hyperoxia; n = 5 bundles). 90 min hypoxia significantly 
impaired Pt and P30 in all L-NMMA tested groups, including in untreated subjects (Repeated measures 
ANOVA). * P < 0.05 compared with time-control. 
 
 37 
 
 
Effects of L-NMMA, Hemoglobin and Sp-NO on contractile properties 
HYPOXIA. Baseline contractile properties. Baseline Pt, P30 and Po were not 
significantly different among the experimental groups (P > 0.05 by one-way 
ANOVA) and averaged 8.0 ± 0.6, 16.1 ± 0.9 and 19.2 ± 1.1 N/cm2, respectively. P30 
was ~ 76 % of Po at 26 ºC.  
Dose-dependent effects of L-NMMA. Fig. 1A and 1B show that ninety minutes of 
severe hypoxia significantly impaired Pt and P30 in all L-NMMA tested groups, as 
well as in untreated bundles (P < 0.001). 1-30 µM L-NMMA induced a progressive 
increase in P30 and Pt as percentage of initial values. Peak increases in P30 (10.8%) and 
Pt (11.5%) were observed at a concentration of 30 μM L-NMMA. The average P30 was 
60 ± 2% and 64 ± 3% of initial value at 1 μM and 10 μM, respectively. The average Pt 
was 55 ± 1% and 62 ± 3% of initial value at 1 μM and 10 μM, respectively. L-NMMA 
in a concentration of 30 μM significantly increased P30 compared to control values 
(59 ± 1% and 69 ±1% in control and L-NMMA group, respectively; P < 0.01; n = 7). 
The rise in Pt was not statistically significant (53 ± 3% and 64 ± 3% in control and 30 
µM L-NMMA groups, respectively; P > 0.05; n = 5). The L-NMMA at concentrations 
of more than 100 µM reduced Pt and P30, as reflected by increased rates of decline of 
P30 and Pt. L-NMMA 1000 µM significantly reduced P30 compared to control (47 ± 
3% in L-NMMA group; P < 0.05). But the reduction in Pt was not statistically 
significant as well (48 ± 5% in L-NMMA group; P > 0.05).  
Fig. 2A shows that the effects of different concentrations of L-NMMA (1- 100 
µM) on P30 of percentage of time control values were significantly different between 
hypoxic and hyperoxic group (P < 0.001 by repeated-measures ANOVA). No 
significant difference of the effects of L-NMMA on Pt were found between hypoxic 
and  hyperoxic groups (P > 0.05; Fig. 2B).  
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Figure. 2. Comparing the effects of L-NMMA on force generation between hypoxic and hyperoxic 
groups.  
A: Submaximal tetanic tension (P30). B: Twitch tension (Pt). Values are means ± SE expressed as 
percentage of time-control values. The effects of L-NMMA (1-100 µM) on P30 is significantly different 
between hypoxic and hyperoxic group (P < 0.001 by repeated-measures ANOVA). The effects on Pt 
did not significantly difference between hypoxic and hypoxic groups (P > 0.05).  
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Effects of Sp-NO and hemoglobin. Sp-NO induced a rapid and significant reduction in 
Pt and P30  (Pt: 79 ± 2% in Sp-NO group vs. 89 ± 4% in control group after 10 min 
equilibration; P < 0.05; 54 ± 3% in Sp-NO group vs. 68 ± 3% in control group after 
30 min equilibration; P < 0.01; P30: 82 ± 2% in Sp-NO group vs. 92 ± 4% in control 
group after 10 min equilibration; P < 0.05; 59 ± 4% in Sp-NO group vs. 78 ± 2% in 
control group after 30 min equilibration; P < 0.01; Fig. 3A and 3B). Sp-NO induced a 
reduction in Po after 10 min but did not alter Po after  
30 min (79 ± 2% in Sp-NO group vs. 89 ± 4% in control group after 10 min 
equilibration; P < 0.05; 74 ± 3% in Sp-NO group vs. 80 ± 3% in control group after 
30 min; P > 0.05; Fig. 3C). Decreases in Pt and P30 by Sp-NO were more pronounced 
at 30 min of incubation. A mean decrease of ~ 22% in Pt was observed after 10 min 
incubation with Sp-NO and a mean reduction of ~ 47% was measured after 30 min 
compared with control. P30 showed ~ 19% decrease after 10 min and ~ 41% decrease 
after 30 min compared to control.  
 Exposure to degraded Sp-NO did not affect force generation at both Pt and P30 
after 10 min and 30 min incubation (P > 0.05; Fig. 3A, 3B and 3C). Furthermore, the 
effects of Sp-NO on Pt, P30 and Po were abolished in the presence of hemoglobin (Pt: 
67 ± 4% in hemoglobin plus Sp-NO group vs. 68 ± 2% in control after 30 min 
equilibration; P > 0.05; P30: 72 ± 3% in hemoglobin plus Sp-NO group vs. 78 ± 2% in 
control after 30 min equilibration; P > 0.05; Fig. 3A and 3B). Hemoglobin alone 
tended to elevate Pt, P30 and Po compared to time-control group but only the rise in P30 
was statistically significant (81 ± 2% in hemoglobin group vs. 74 ± 2% in control 
group after 30 min equilibration; P < 0.05; n = 7; Fig. 5A). 
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Figure. 3. Rat diaphragm force generation after 10 min and 30 min incubation with 1 mM spermine 
NONOate (Sp-NO) during hypoxic conditions. A: twitch tension (Pt ). B: submaximal tetanic tension 
(P30). C: maximal tetanic tension (Po). Values are means ± SE expressed as percentage of initial values. 
Sp-NO reduced Pt, P30 after 10 min and 30 min incubation compared to timed-control (n = 8 bundles) 
but did not alter Po after 30 min (P > 0.05). Effects of Sp-NO were more pronounced at 30 min 
incubation. Exposure to degraded Sp-NO did not affect Pt ,P30 and Po both after 10 min and 30 min (n = 
6 bundles). The effects of Sp-NO on Pt and  P30 were abolished in the presence of hemoglobin (n = 8 
bundles). Deg Sp-NO = degraded Sp-NO. * P < 0.05 compared with time-control. 
 
HYPEROXIA. Baseline contractile properties. Baseline Pt, P30 and Po were not 
significantly different between all experimental groups (P > 0.05 by one-way 
ANOVA). Fig. 1A and 1B show that after 90 min Pt and P30 were significantly higher 
during hyperoxia compared with hypoxic conditions  (P < 0.001). 1-10 µM L-NMMA 
improved P30 and Pt in a dose-dependent manner. A peak increase (11.8 %) in P30 was 
observed with a concentration of 10 μM L-NMMA. High concentrations (> 30 µM) 
decreased P30 and Pt but no significant effects were found. Sp-NO did not affect Pt, 
P30 and Po after 10 min and 30 min administration (P > 0.05; Fig. 4). Hemoglobin 
significantly increased Pt, P30 and Po after 30 min incubation (P < 0.05; Fig. 5B). 
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Figure. 4.  Relative diaphragm twitch tension (Pt), submaximal tetanic tension (P30) and maximal 
tetanic tension (Po) changes after10 min and 30 min incubation with 1 mM Sp-NO during hyperoxic 
conditions.  
Values are expressed as percentage of initial values. 1 µM Sp-NO did not affect Pt ,P30 and Po  after10 
min and 30 min treatment compared with time-control (P > 0.05; n = 8 bundles).    
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Figure. 5. Relative diaphragm twitch tension (Pt ), submaximal tetanic tension (P30) and maximal 
tetanic tension (Po) changes after 30 min incubation with 150 µM hemoglobin. Values are expressed as 
percentage of initial values. A: under hypoxic conditions hemoglobin increased P30 (n = 7 bundles). B: 
under hyperoxic conditions hemoglobin increased Pt, P30 and Po ( n = 7 bundles). * P < 0.05 compared 
with time-control.   
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Discussion  
The present study demonstrates that 1) Severe hypoxia impairs force generation in 
vitro of the rat diaphragm. L-NMMA has dose-dependent effects on in vitro force 
generation of the unfatigued diaphragm during hypoxia. Low concentrations of L-
NMMA improve the force generation, but higher concentrations of L-NMMA, which 
are likely to inhibit NO release completely, reduce force generation. Comparing the 
effects of L-NMMA on force generation between hypoxia and hyperoxia, the effects 
were more pronounced during hypoxia. Similar results as with low concentrations of 
L-NMMA were obtained with hemoglobin, namely an increase in the force generation 
of rat diaphragm during hypoxia. Supplementation of exogenous NO by Sp-NO 
accelerated the hypoxia-induced force reduction; the effects of Sp-NO were abolished 
in the presence of hemoglobin during hypoxia. 2) The concentration of L-NMMA 
needed for an optimal force generation was higher during hypoxia compared to 
hyperoxia (30 μM vs. 10 μM). Incubated with the same concentration of hemoglobin 
in hypoxic diaphragm the force generation reached less optimal levels compared to 
hyperoxia. Furthermore, in sharp contrast to its effect under hypoxia, Sp-NO did not 
affect the force generation during hyperoxia. These results indicate that NO plays a 
more prominent role in the force reduction during hypoxia compare to hyperoxia. NO 
contributes to the depression of force generation of hypoxic rat diaphragm in vitro 
 
Pharmacology of L-NMMA, Sp-NO and Hemoglobin 
L-NMMA, a amino acid analog of L-arginine, is an established inhibitor of NO 
generation in varied of tissue including skeletal muscle cell in vitro (4; 6; 13). It 
competes with arginine for binding on NOS molecules and equally inhibits all three 
isoforms of NOS (eNOS, nNOS and iNOS) (26). L-NMMA also inhibits L-arginine 
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transport into cultured cells (Edwards et al. 1998). Incubation time with 90 min was 
used in the present study in vitro for several reasons. Firstly, 10 µM L-NMMA 
decreased the release of NO in isolated rat extensor digitorum longus muscle (EDL) 
by 68% after 1 h incubation (4). Secondly, the effect of L-NMMA is long-lasting (4; 
30; 36). For instance, the inhibition of endothelium-dependent relaxation of rings of 
rabbit aorta by L-NMMA was fully reversible after washing for 90 min. Finally, pilot 
data from our laboratory (not shown) demonstrated that the time-dependent effects of 
L-NMMA on submaximal tetanic force in vitro were pronounced after 60 min and 90 
min of incubation during hypoxia.  
Hemoglobin is known to bind avidly and to nullify rapidly the effects of NO 
and thus to act as a scavenger (15). The affinity of NO for hemoglobin is about 1500 
times that of CO in the absence of oxygen (22). It was shown that hemoglobin 
enhanced submaximal force generation of rat diaphragm in vitro (23). The present 
data showed that hemoglobin is also able to prevent responses mediated by 
endogenous NO in diaphragm muscle in vitro under hypoxic conditions. Like 
superoxide dismutase (SOD), hemoglobin may scavenge NO generated intracellular 
muscle cells by creating a gradient diffusion of NO out of the cell “sink” (24).   
Sp-NO, a nucleophilic type of NO donor with the general structure 
[XN(O)NO]- adducts, decomposes non-enzymatically and releases NO extracellular 
in solution (32). The rate of NO release from this type of donors only depends on the 
pH and temperature of the solution and the nucleophilic residue (32). Sp-NO 
generates NO in a short time and long-lasting manner (32; 41). It required 15 min to 
reach peak relaxation of aortic segments and maintained this level throughout the 
experiment (60 min) (32).  
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Muscle Function during Hypoxia 
The present study showed that hypoxia impairs force generation, including Pt, P30 and 
Po in the rat diaphragm. These data are in line with previous studies of hypoxia on 
isometric diaphragm contractility in vitro (18; 29). Since maximal isometric force 
correlates with the number of active cross-bridge (33), this result indicates that 
hypoxia impaired cross-bridge recruitment or reduced force per cross bridge. At a pO2 
~ 7 kPa (~ 54 mmHg) Pt ,P30 and P o were reduced by 32%, 23% and 19% in the 
control group after 30 min (Fig. 5A, 5B and 5C); Pt and P30  were reduced by 48% and 
42%, respectively, after 90 min of hypoxia (Fig. 1A and 1B), suggesting that hypoxia-
induced force reduction increased over time.  
The decline in force generation during hypoxia may have several reasons (42). 
These mechanisms include: increased production of ROS, down- regulation of 
mitochondrial enzymes and reduced sarcolemmal excitability. Whether or not NO is 
involved in these changes is uncertain. But it was known that hypoxia enhances the 
generation of ROS (12) and antioxidants decreased the force generation of rat 
diaphragm in vitro (18). Increasing evidence also shows that biological activities of 
NO and ROS are strongly inter-dependent, since their redox-derivatives compete for 
the same metal center and thiol groups on target proteins (1; 25; 37). In addition, the 
affinity for NO to superoxide is high (35). 
 
Effects of NO on force generation during hypoxia  
The present study showed that L-NMMA has dose-dependent effects on force 
generation of the rat diaphragm during both hypoxia and hyperoxia. L-NMMA at low 
concentrations improves the P30 but L-NMMA at high concentrations reduces P30. A 
increase in P30 by low concentrations of L-NMMA is in line with the previous 
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observations during hyperoxia (23; 39), indicating that NO inhibits ECC in unfatigued 
muscle. L-NMMA > 30 µM may inhibit endogenous NO generation completely in the 
diaphragm. L-NMMA 10 µM has been shown to decrease the release of NO by 68% 
in rat EDL muscle (4) and the NOS activity in diaphragm is lower than that in EDL 
muscle (5.2 vs. 13.5 pmol min -1 mg -1 protein respectively) (23). A reduction of force 
by higher concentrations of L-NMMA suggests that some amount of NO is needed to 
maintain diaphragm muscle function. Theoretically, very high concentration of L-
NMMA may also have direct toxic effects on muscle performance.  
The present results indicate that NO has a more prominent role during hypoxia 
than hyperoxia, and that NO depresses isometric contractility of rat diaphragm in vitro 
during hypoxia. Firstly, during hypoxia low concentrations of L-NMMA 
progressively increased force generation of rat diaphragm. The concentration of L-
NMMA needed for an optimal force generation was higher compared to hyperoxic 
conditions (30 μM vs. 10 μM), which implies that NO generation or NOS activity 
could be elevated during hypoxia. Moreover, the increase effects of L-NMMA on P30 
were more significant during hypoxia than hyperoxia, suggesting that NO plays a 
more prominent role in hypoxia-induced force reduction. Secondly, after incubation 
with the same concentration of hemoglobin the force generation of the hypoxic 
diaphragm was increased less compared to hyperoxic diaphragm (6% and 5% of P30 
and Pt, respectively vs. 11% and 16% of P30 and Pt , respectively). To  reach optimal 
force production it is likely that higher concentrations of hemoglobin are needed to 
scavenge the large amount NO generated during hypoxia. It is unlikely there would be 
less NO generation in hypoxia for hemoglobin to bind, which could be another 
explanation why the effect of hemoglobin on force generation is more pronounced in 
hyperoxia than in hypoxia. Because the present study showed that a higher dose of L-
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NMMA is needed to scavenge endogenous NO during hypoxia than during hyperoxia. 
In addition, hypoxia is unlikely to affect the affinity of NO for hemoglobin based on 
the fact that NO combines with hemoglobin to form nitrosyl-hemoglobin during 
hypoxia (22). Moreover, the affinity of NO for hemoglobin is higher in the absence of 
oxygen (22). It is also possible that hemoglobin was saturated with NO during 
hypoxia, which could be another possibility that hemoglobin increased P30 and Pt less 
compared to hyperoxia.   
Finally, exposing muscle to an NO donor, the hypoxic-induced reduction in 
force generation was accelerated dramatically. Sp-NO induced a significant reduction 
in Pt, P30 and Po. It is important to note that the effects of Sp-NO were abolished in the 
presence of hemoglobin during hypoxia and that exposure to degraded Sp-NO did not 
affect both Pt and P30. This indicated that NO release indeed mediates the effects of 
Sp-NO. The absence of an effect of degraded Sp-NO is consistent with a previous 
report in skeletal muscle and smooth muscle (17; 20). In sharp contrast to the 
significant reduction in force generation under hypoxia, Sp-NO did not affect Pt , P30  
and Po during hyperoxia. This finding is consistent with data reported previously. NO 
donors, i.e. sodium nitroprusside (SNP) and S-nitroso-N-acetylcysteine (SNAC), did 
not alter submaximal tetanic force and Po in normal rat diaphragm (23; 25; 33). These 
results imply that diaphragmatic muscle cells might be able to adjust the NO 
concentration during hyperoxia. It has been shown that NO can adjust its own 
synthesis by feedback inhibition in restricting NO production (7). Conversely, 
hypoxia might affect NO scavenging properties of the muscle, which could result in 
elevated NO generation in the hypoxic muscle. It is unlikely that NO released from 
Sp-NO might be scavenged by O2 in hyperoxic solutions, which could induce the lack 
of effects of Sp- NO on force generation. As a gas, NO reacts with O2 to produce 
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nitrogen dioxide, but in solution Sp-NO release NO spontaneously, NO can diffuse 
rapid through cells and tissues (22). A previous study (20) confirmed that 30 µM Sp-
NO decreased in vitro isometric force in smooth muscle aerated with 94% O2/6% CO2 
(pO2 = 71 kPa (~ 547 mmHg)). Taking together, the effects of NO on force reduction 
were more pronounced in hypoxia. NO contributes to the depression of in vitro force 
generation in rat diaphragm during hypoxia. This modulation might be related to the 
elevated NO generation during hypoxia.  
NO depresses force generation of skeletal muscle mainly via cGMP-
independent processes, which directly modulate regulation proteins via redox effects 
(38). Ca 2+ release ryanodine receptor (RYR1) channels of the sarcoplasmic reticulum 
(SR) are likely sites for such interaction (1). The thiol groups presented on these 
channels are possible targets (28) (19). Low concentrations of NO prevent channel 
opening from oxidation induced activation, in this way reducing the rate of Ca2+ 
release, but high concentrations promote opening of the RYR1 channels (1). The data 
from our own laboratory (17) also demonstrated that in permeabilized rabbit psoas 
muscle fibers NO donor reduces Ca 2+ sensitivity, which would contribute to the 
reduction of force generation. Another potential target is reactive thiols presented on 
the myosin head (34). This would reduce the maximal force generation and is 
therefore partially consistent with the current study.  
Data on NO production in skeletal muscle exposed to acute hypoxia are not 
available to our knowledge. However, in coronary endothelial cells, 30 min and 120 
min of  hypoxia (pO2 = 1.3 kPa (~ 10 mmHg)) significantly activated the constitutive 
nitric oxide synthase (44). The mechanism underlying the increase in nitric oxide 
production is not known. An increase in [Ca2+]i under hypoxic conditions (10) (45) 
may serve as a seconded messenger  to active NOS (16). Increases in NOS in 
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pulmonary artery endothelium with hypoxia (4.9 kPa (~ 38 mmHg)) triggered by the 
initial transient  increase in [Ca2+]i (16). Further studies are necessary to unravel these 
mechanisms.  
 
Clinical relevance  
 
In patients with severe COPD chronic hypoxia can frequently be found. Moreover, 
during exacerbation of their disease, acute hypoxia may be present. Hypoxia reduces 
diaphragm contractility in vitro and reduces fatigue resistance in vitro and in humans 
(18; 21). Several studies (23; 25) have shown that NO affects ECC in striated muscle, 
and that O2 tension is an important factor in regulating NO synthase in vitro system 
(16). Investigating the role of NO in the diaphragm contractility during hypoxia is of 
particular interest. The present study indicates that reduction of NO generation 
improves the force generation of the rat diaphragm in vitro during hypoxia. 
Specifically, the dose-dependent effect of L-NMMA suggests to select a 
concentration of NOS inhibitor, which has a minimal effect on physiological, NO 
production, which is important for maintaining muscle function. Whether or not this 
protection effect by a NOS inhibitor during hypoxia can be generalized in clinical 
conditions, is too early to speculate, because sufficient rational exist for dual actions 
of NO (8). Future investigations are needed to determine the role of NO in modulation 
muscle contractility of diaphragm in vivo.  
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Abstract 
Nitric oxide (NO) is essential for optimal myofilament function of the rat diaphragm 
in vitro during active shortening. Little is known about the role of NO in muscle 
contraction under hypoxic conditions. Hypoxia might increase the NO synthase 
(NOS) activity within the rat diaphragm. We hypothesized that NO plays a protective 
role in isotonic contractile and fatigue properties during hypoxia in vitro. The effects 
of the NOS inhibitor NG-Monomethyl-L-arginine (L-NMMA), the NO scavenger 
hemoglobin and the NO donor Spermine NONOate (Sp-NO) on shortening velocity, 
power generation and isotonic fatigability during hypoxia were evaluated (pO2 ~ 7 
kPa). L-NMMA and hemoglobin slowed the shortening velocity, depressed power 
generation and increased isotonic fatigability during hypoxia. The effects of L-
NMMA were prevented by co-administration with the NOS substrate L-arginine. Sp-
NO did not alter isotonic contractile and fatigue properties during hypoxia. These 
results indicate that endogenous NO is needed for optimal muscle contraction of the 
rat diaphragm in vitro during hypoxia.  
 
Introduction 
Skeletal muscle including the diaphragm continuously produces nitric oxide (NO) (4, 
26). NO is produced in biological systems via the enzymatic action of NO synthase 
(NOS) (32). NO generation by the constitutive NOS isoforms (neuronal NOS (nNOS) 
and endothelial NOS (eNOS)) is calcium-dependent (16). NO production within 
skeletal muscle is enhanced during contractile activity (5).  
NO has been shown to modulate contractile properties of skeletal muscle in 
vitro. The overall effect depends on the experimental paradigm. Inhibition of NOS 
increases twitch and submaximal tetanic force of the rat diaphragm. These alterations 
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are reversed by NO donors (26), suggesting that NO inhibits excitation-contraction 
coupling in unfatigued muscle. On the other hand, NO is essential for optimal 
myofilament function in the rat diaphragm during active shortening in vitro (36). 
Inhibition of NOS decreases the shortening velocity and power generation of the rat 
diaphragm under hyperoxic conditions (36). These findings of NOS inhibition on 
force generation and velocity of shortening indicate multiple possible targets for NO 
in skeletal muscle. In fatiguing contractions supplementation with exogenous NO 
slowed the decline of maximal force in mouse soleus muscle (38). This finding 
suggests that NO preserves skeletal muscle function in vitro during strenuous 
contractile activity.  
Hypoxia impairs force generation and accelerates skeletal muscle fatigue in 
vitro (21, 48). To date no study has investigated the role of NO in shortening velocity 
or isotonic fatigability during hypoxia. This is of particular interest because NO 
affects excitation-contraction coupling in striated muscle (26) and O2 tension is an 
important factor in regulating NOS in an in vitro system (19). Furthermore, the 
isotonic contractile properties better reflect diaphragm muscle performance in vivo 
(46). Hypoxia impairs the sarcoplasmatic reticulum (SR) Ca2+ re-uptake from the 
intracellular space (12, 52). This could result in an increase of intracellular Ca2+ levels 
([Ca2+]i), and may, in turn, potentiate NO production by Ca2+ dependent NOS (19). 
Based on previous studies showing that NO facilitates the shortening velocity and 
preserves muscle function (36, 38), we hypothesized that NO has a protective role in 
hypoxia-mediated modulation of muscle contraction in the rat diaphragm in vitro. 
Accordingly, the aim of the present study was to investigate the effects of the NOS 
inhibitor NG-Monomethyl-L-arginine (L-NMMA), the NO scavenger hemoglobin and 
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the NO donor Spermine NONOate (Sp-NO) on the shortening velocity, power 
generation and fatigue endurance of rat diaphragm during hypoxia in vitro.  
 
Methods 
General procedures 
Adult male outbred Wistar rats with a mean body weight of 310 ± 10 (SE) g were 
used. The rats were anesthetized with pentobarbital sodium (70 mg/kg body wt ip). 
Diaphragm bundles were prepared as previous described (21). Briefly, a tracheotomy 
was performed, and a polyethylene cannula was inserted. The animals were 
mechanically ventilated with 100% oxygen. The diaphragm and adherent lower ribs 
were quickly excised, and were immediately submersed in cooled oxygenated (95% 
O2-5% CO2) Krebs solution at pH ~ 7.4. This Krebs solution consisted of 137 mM 
NaCl, 4 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 1 mM KH2PO4, 24 mM NaHCO3, and 7 
mM glucose and 25 μM d-tubocurarine (Sigma, Bornem, Belgium). One rectangular 
strip was dissected from the central costal region of the hemidiaphragm. Silk sutures 
were tied firmly to both ends.  
 
Contractile Measurements 
Contractile properties were measured as described previously (21).  Briefly, the 
insertion of the muscle bundles at the costal margin was attached to a metal clamp. 
The suture attached to the central tendon was connected to the lever arm (Cambridge 
Technologies, model 308B). The Cambridge system was controlled by using the 
software program Poly 5.0 (Inspektor Research Systems, Amsterdam, The 
Netherlands). Length and force outputs were digitized by using a data-acquisition 
board (DASH 1602, Keithley) at a sampling frequency of 2.0 kHz. The muscle was 
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stimulated directly with platinum plate electrodes. Rectangular current pulses (0.5 ms) 
were generated by a stimulator (ID-electronics, University of Nijmegen) activated by 
a personal computer. The strip was stimulated 1.25 times the current needed for 
maximal activation (~ 200-250 mA). Muscle preload force was adjusted until the 
optimal fiber length  (Lo) for maximal twitch force  (Pt) was achieved. 
 The Cambridge system was first set for length control (isometric mode). After 
15 minutes of thermo-equilibration during hyperoxia (95% O2 and 5% CO2; 26°C) Pt 
and maximal tetanic force at 100 Hz (Po) were measured twice with a 2 min interval. 
Subsequently, the perfusion of the tissue bath was either maintained with hyperoxia or 
switched to hypoxia (95% N2 and 5% CO2; 26°C); the Krebs solution was changed to 
the experimental conditions (see treatment groups). After either 60 min or 30 min of 
incubation, Pt and Po were re-measured. The Cambridge system was then set for force 
control (isotonic mode). The muscle was simulated at 100 Hz (330-ms train duration) 
while force was clamped at different levels ranging from 1 to 100% of Po. There was 
a 2-min interval between each force clamp level. The muscle shortening velocity at 
each load clamp is expressed as muscle lengths per second (Lo/s). To determine 
isotonic fatigue, the load clamp was set for maximal power output (~ 33.3% Po), and 
the muscle was stimulated at 100 Hz (330-ms train duration) every 2 seconds. 
Stimulations continued until no muscle shortening could be observed, and this period 
was defined as the isotonic endurance time. 
 
Effects of L-NMMA, hemoglobin, L-arginine and Sp-NO  
The effects of L-NMMA (NG –Me-L-Arg, AcOH, Calbiochem, Breda, The 
Netherlands), hemoglobin (Bovine, Sigma Chemical, Zwijndrecht, the Netherlands) 
and Sp-NO ([N - (2-Aminoethyl)- N - (2-hydroxy-2-nitroso-hydrazino) -1, 2-
ethylenediamine; NOC-22]; Calbiochem, Breda, The Netherlands) on the isotonic 
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contractile and fatigue properties were determined during hypoxia. Previously it was 
shown that 10 µM L-NMMA decreased the release of NO in isolated rat extensor 
digitorum longus muscle (EDL) by 68% after 1 h incubation (5), and that the NOS 
activity in diaphragm is lower than that in EDL muscle (26). Therefore, a final 
concentration of L-NMMA of 10 µM and an incubation time of 60 min were used in 
the present study. To exclude the NOS independent effects of L-NMMA, 30 µM L-
arginine, the NOS substrate (Sigma Chemical CO, Germany) was administrated 
simultaneously to the Krebs solution, since L-arginine in a threefold concentration 
reverses completely the effect of L-NMMA on endothelium-dependent contractions in 
vitro (9, 42). To assess the effects of hypoxia on contractile properties similar 
measurements were performed under untreated hyperoxic conditions (with 60 min of 
incubation). 
To ascertain that the effects of L-NMMA on contractile properties and isotonic 
fatigability were indeed mediated by NOS inhibition, similar experiments were 
performed with hemoglobin. Hemoglobin 150 µM was administrated based on the 
previous observation from the study of Kobzik et al (26). Hemoglobin 50 µM did not 
significantly increase the force generation but 50-250 µM did enhance submaximal 
force generation in normal diaphragm.  
Moreover, the effects of Sp-NO (1 mM) were tested to determine if the 
contractile properties were also sensitive to exogenous NO. Sp-NO was added directly 
to the solution in the tissue bath (45). Compared with other nucleophilic adducts, Sp-
NO releases NO slowly (half-life time 39 min) (31). The action of these agents 
correlates strongly with the amount of NO they release in aqueous buffers (35). The 
maximal vasodilator effect in rabbit aortic rings was achieved at 15 minutes after 
addition of Sp-NO. This effect remained constant for 60 minutes (35). Under 
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physiological conditions, Sp-NO generates ~ 1.9 mol of NO/mol of adducts (high 
ENO), but the concentration of Sp-NO to produce 50 % relaxation in aortic rings is 
higher than other nucleophilic adducts (31). Based on these physicochemical 
properties, and previous studies in skeletal muscle (20), 30 min of incubation time and 
a concentration of 1 mM Sp-NO were used to produce NO in the current study. The 
effects of L-NMMA, L-arginine and Sp-NO on isotonic contractile and fatigue 
properties were compared with that in standard Krebs solution during hypoxia.  
Accordingly, seven experimental groups were studied: hyperoxia control (n = 
6), hypoxia control for L-NMMA experiment (n = 8), hypoxia plus L-NMMA (n = 8), 
hypoxia plus L-NMMA + L-arginine (n = 8), hypoxia control for Sp-NO experiment 
(n = 8), hypoxia plus Sp-NO (n = 8), hypoxia plus hemoglobin (n = 7). The 
diaphragm bundles were randomly allocated to the treatment groups. 
To verify the experimental conditions in the present study, pCO2, and pO2 of 
the Krebs solutions were measured after completion of the contractile experiments. 
pH was measured at regular intervals throughout the experimental protocol. The 
system used in the present study was a flow through chamber that was continuously 
bubbled with gas mixtures.  
 
Data Treatment and Statistics 
After each experiment, muscle bundles length and weight were determined, 
respectively. Cross-sectional area (CSA) was calculated by dividing diaphragm strip 
weight (in g) by strip length (in cm) times specific density (1.056). Force is expressed 
as per CSA (in N/cm2). The time window for shortening velocity measurements was 
set to begin 10 ms after the first detectable change in length. Force-velocity 
characteristics were plotted with respect to P/Po. The data were fitted to the Hill (23) 
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equation: (P + a)(V + b) = (Po + a) b, where P is force, Po is maximum isometric 
force, V is velocity of shortening and a and b are constants with dimension of force 
and velocity, respectively. The curvature of the force-velocity relationship, a/Po, can 
be derived from this equilibration. The constants b and a were calculated using a 
computer program (Fig. P for Windows v 2.7; Fig. P Software, Durham, NC) that 
fitted the data to the Hill equation. Power [force (N/cm2) × shortening velocity (Lo/s)] 
was calculated for each load clamp release and plotted with respect to load.  
 Differences in single baseline contractile properties, bundles dimensions, and gas 
pressure among the experimental groups were analyzed with one-way ANOVA and if 
appropriate, Student-Newman-Keuls (SNK) post hoc testing. Parameters requiring 
repeated-measures over time (e.g., force-velocity, force-power, fatigue) were estimated 
by using repeated-measures models and if appropriate, SNK post hoc testing. Statistical 
analysis was performed with the SPSS package version 10.0 (SPSS, Chicago, IL). 
Data are expressed as means ± SE. Comparisons were considered significant at P < 
0.05.  
 
RESULTS 
Verification of tissue bath hypoxia and strip dimensions 
Perfusion of the tissue baths with the hypoxic gas mixture reduced pO2 in the Krebs 
solution to ~ 7.2 ± 0.2 kPa in all of the hypoxic groups, as compared with 84.8 ± 0.9 
kPa in the hyperoxic group (P < 0.001). No differences were found in pCO2 and pH 
among all experimental groups  (P > 0.05). pH was 7.38 ± 0.01 in the hypoxic groups 
and 7.36 ± 0.01 in the hyperoxic group; average pCO2 was 4.7 ±  0.1 kPa in the 
hypoxic groups and 4.8 ± 0.2 kPa in the hyperoxic group.  
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Diaphragm muscle strip dimensions were not significantly different among the 
experimental groups (P > 0.05). Average muscle strip weight was 37.1 ± 0.8 mg, and 
strip length at Lo was 18.8 ± 0.8 mm.  
 
Isotonic contractile and fatigue properties during hypoxia  
Baseline contractile properties. Baseline Pt and Po were not different among the 
experimental groups (P > 0.05). Mean values of Pt were 7.2 ± 0.3 N/cm2 in the 
hypoxic groups and 8.0 ± 0.4 N/cm2 in the hyperoxic group; average baseline values 
of Po were 23.1 ± 0.8 N/cm2 in the hypoxic groups and 25.3 ± 1.2 N/cm2 in the 
hyperoxic group, respectively. Fig. 1A show that sixty minutes of hypoxia reduced Pt, 
Po by 21% and 18%, respectively, compared to hyperoxia control (P < 0.01).  
L-NMMA tended to elevate Pt compared to control during hypoxia (P = 0.09; 
Fig. 1A) but did not alter Po. Pt and Po were not different between L-NMMA plus L-
arginine groups and control groups during hypoxia. Incubated with 1 mM Sp-NO 
during hypoxia, Pt was lower compared to control groups (P < 0.05; Fig. 1B) but Po 
was not different. Hemoglobin did not significantly affect Pt and Po compared to 
control groups during hypoxia. 
Force-velocity and force-power characteristics during hypoxia. L-NMMA 
slowed the shortening-velocity over a wide range of loads during hypoxia (P < 0.01; 
Fig. 2A). Vmax of the L-NMMA group was ~ 28% lower than in the hypoxia control 
(P < 0.05; Fig. 2B). L-NMMA did not alter the curvature of force-velocity 
relationship, as described by a/Po (0.28 ± 0.05 in L-NMMA group and 0.27 ± 0.03 in 
60 min of hypoxia control, respectively; P > 0.05). L-arginine abolished the 
detrimental effects on Vmax caused by L-NMMA (P > 0.05; Fig. 2B). The force-
velocity relationship did not differ between control groups and L-NMMA plus L-
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arginine groups (P > 0.05) and did significantly differ between L-NMMA groups and 
L-NMMA plus L-arginine groups (P < 0.05). Sp-NO did not alter the shortening-
velocity relationship compared to hypoxic control (Fig. 3B). Hemoglobin slowed the 
shortening-velocity over a wide of range of loads during hypoxia (P < 0.05; Fig. 3A). 
Vmax fell ~ 22% in hemoglobin-treated muscle compared to hypoxia control (P < 0.05; 
Fig. 3B). a/Po measured in 30 min of hypoxic control was 0.14 ± 0.01 and was 
unchanged by hemoglobin (0.18 ± 0.07; P > 0.05). Force-velocity relationship was 
not different between hyperoxia control and hypoxia control, including Vmax (Fig. 2A 
and 2B). a/Po, however, was lower in 60 min of hyperoxia control compared to 60 
min of hypoxia control (0.13 ± 0.03 vs. 0.27 ± 0.03, respectively).        
L-NMMA depressed the power output over a wide range of loads during 
hypoxia (P < 0.01; Fig. 4A). This effect was most marked in the region of peak power 
(51 ± 4 and 83 ± 8 N/cm2 × Lo/s in L-NMMA and hypoxia control, respectively; P < 
0.001). Co-incubation of muscle bundles with L-arginine prevented the depression of 
power outputs caused by L-NMMA. Sp-NO did not affect the power output including 
the peak power during hypoxia. Hemoglobin depressed power production over a wide 
range of loads during hypoxia (P < 0.01; Fig. 4B). There was no significant difference 
in the force-power relationship between the hypoxia and hyperoxia control groups  
(Fig. 4A). 
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Figure 1.  Diaphragm maximal twitch tension (Pt) and maximal tetanic tension (Po) after 60 min (A) 
and 30 min (B) in experimental Krebs solution. Values are expresses as percentage of initial values. A: 
L-NMMA tended to elevate Pt during hypoxia (pO2 ~ 7.2 kPa; P = 0.09; n = 6) but did not alter Po. 
Incubation with L-NMMA plus L-arginine to muscle did not affect Pt and Po. Hypoxia impaired both Pt 
and Po compared to hyperoxic control (pO2 ~ 85 kPa; P < 0.01). B: Spermine NONOate (Sp-NO, 1 
mM) reduced Pt but did not affect Po during hypoxia (n = 7). Hemoglobin treatment (n = 7) did not 
affect Pt and Po.  
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Figure 2. Force-velocity relationship in the rat diaphragm after 60 min of incubation in experimental 
Krebs solution. A: L-NMMA slowed the shortening-velocity over a wide range of loads compared to 
hypoxia control (n = 8; P < 0.01) but did not alter the curvature during hypoxia. Effects were partly 
reversed by co-administration with 30 µM L-arginine. Hypoxia did not affect force-velocity 
relationship compared to hyperoxic control (n = 6). B:  Bar graph highlights Vmax for the same four 
groups. Vmax was slower in the L-NMMA groups. Effect was abolished by co-administration with L-
arginine. Hypoxia did not affect Vmax compared to hyperoxic control. * P < 0.05 compared with 
hypoxia control. 
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Figure 3. Force-velocity relationship in the rat diaphragm after 30 min of incubation in experimental 
Krebs solution.  A: During hypoxia Sp-NO did not affect the force-velocity relationship (n = 8), and 
Hemoglobin slowed the shortening-velocity over a wide range of loads (P < 0.05; n = 7) but did not 
alter the curvature of force-velocity relationship. B:  Bar graph highlights Vmax for the same three 
groups. Sp-NO did not affect Vmax. Vmax was slower in hemoglobin-treated muscle. * P < 0.05 
compared with hypoxia control. 
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Figure 4.  Force-power relationship from rat diaphragm after 60 min (A) and 30 min (B) of 
incubation in experimental Krebs solution.  A: L-NMMA depressed the power output over a wide 
range of loads during hypoxia (P < 0.01). Effects were prevented by co-incubation with L-arginine.  
Hypoxia did not affect force-power relationship compared to hyperoxic control. B: Sp-NO did not 
affect the power output during hypoxia while hemoglobin depressed power production over a wide 
range of loads (P < 0.01).  
 
 69 
 
 
Isotonic fatigue properties during hypoxia. With repetitive contractions, power output 
of the diaphragm progressively declined over time in all experimental groups (Figure. 
5A and 5B). In the L-NMMA groups the rate of decline in power output was faster 
and isotonic endurance was less than that in control groups (P < 0.05; Fig. 5A and 
6A). These effects were prevented by co-administration with L-arginine (P > 0.05 
compared to hypoxic control; Fig. 5A and 6A). During hypoxia Sp-NO did not affect 
the rate of decline in power output and fatigue endurance compared to hypoxia 
control (Figures 5B and 6B).  Hemoglobin increased the rate of decline in power 
production (P < 0.01), and reduced isotonic endurance compared to hypoxic control 
(P < 0.05; Fig. 5B and 6B). Power output of the diaphragm muscle declined faster in 
hypoxic control compared to hyperoxic control (P < 0.001; Fig 5A). Isotonic 
endurance was 143 ± 11 s and 70 ± 2 s in hyperoxic control and hypoxic control, 
respectively (P < 0.001; Fig. 6A). 
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Figure 5.  Power production during repetitive isotonic contractions in the rat diaphragm after 60 min 
(A) and 30 min (B) of incubation in experimental Krebs solution. 
A: The rate of decline in power production was faster in the L-NMMA groups compared to control 
during hypoxia (P < 0.05); Effect was prevented by co-incubation with L-arginine. Power output 
declined faster in hypoxia compared to hyperoxic control (P < 0.001). 
B: Sp-NO did not affect the rate of decline in power output while power production in hemoglobin-
treated muscle was faster compared to hypoxia control.  
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Figure 6. Mean isotonic fatigue endurance in the rat diaphragm after 60 min (A) and 30 min (B) of 
incubation in experimental Krebs solution. 
A: Endurance time in L-NMMA group is less than that in hypoxic control. The effects were prevented 
by co-administration with L-arginine. Hypoxic reduced the endurance time compared to hyperoxic 
control. * P < 0.05 compared with hypoxia control. # P < 0.05 compared with hyperoxia control. 
B: Sp-NO did not prolong isotonic endurance while hemoglobin reduced endurance time during 
hypoxia. * P < 0.05 compared with hypoxia control.   
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Discussion 
The main finding of the present study is that either inhibition of NOS by L-NMMA or 
scavenging NO by hemoglobin slowed velocity of shortening, depressed power 
generation and increased the fatigability of the rat diaphragm in vitro during hypoxia. 
These data indicate that endogenous NO is needed for optimal muscle contraction of 
the rat diaphragm during hypoxia. Thus endogenous NO has a protective role in 
hypoxia-mediated modulation of  muscle contraction in vitro. Supplementation of 
exogenous NO with Sp-NO did not affect velocity of shortening, power generation 
and fatigability during hypoxia. 
 
L-NMMA, Hemoglobin and Sp-NO  
L-NMMA is an established NOS inhibitor in vitro, and is a naturally occurring 
inhibitor as well (5, 25). It competes with arginine for binding on NOS molecules. It 
also inhibits L-arginine transport into cultured cells to restrict the availability of NOS 
substrate (14, 29). During hypoxia the depressed effects of L-NMMA on Vmax, power 
generation and fatigue resistance were prevented by L-arginine. This indicates that the 
effect of L-NMMA is mediated by NOS modulation. Hemoglobin is known to bind 
avidly and to nullify rapidly the effects of NO (18). Thus it was used as another 
evidence that the observed responses were NO mediated. Since hemoglobin does not 
enter cells and it scavenges NO extra-cellularly (37), it may scavenge NO generated 
intra-cellular by creating a diffusion gradient of NO out of the cell “sink” (27).   
Sp-NO, a nucleophilic type of NO donor, is capable of generating NO extra-
cellular, by a non-enzymatic process in simple aqueous buffers (24, 31). The rate and 
extent of NO release depend on the pH, temperature of the solution (34). Specially, 
this type of NO donors is unique in their ability to generate NO in a predictable 
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manner. Compared with other nucleophilic adducts, Sp-NO generates NO in a long 
lasting and a constant manner (35). Therefore, it is an ideal vehicle for the delivery of 
NO in the current study.  
 
Effects of hypoxia on isotonic contractile and fatigue properties 
The Krebs solution pO2 in the present study was reduced to ~ 7 kPa. This pO2 would 
not ordinarily be regarded as severe hypoxia if it were the arterial pO2  (7), since, in 
vivo, the O2 is carried by the blood delivering of O2 to the muscle cells efficiently. 
Conversely, there is a larger diffusion distance between bath O2 and muscle cells in 
vitro (46). Thus, it is likely that the degree of tissue hypoxia is “severe” in our 
experiment (46, 48). Hypoxia impaired Pt and Po and did not affect force-velocity and 
force-power relationship, which is in line with the data from the previous studies (21, 
48). Velocity of shortening is associated with myosin-adenosine triphosphatase 
(ATPase) activity and determined by the rate of cross-bridge cycling (6), therefore, 
hypoxia did not reduce myosin ATPase activity of the diaphragm fibers. The different 
effects of hypoxia on force generation and shortening of velocity are more likely due 
to the different underlying cellular mechanisms (2). However, hypoxia altered the 
curvature of the force-velocity relationship. The force-velocity relationship was less 
curved after 60 min of hypoxia (higher value of a/Po). A high value of a/Po probably 
indicates a less efficient muscle in terms of energetics (51). 
Hypoxia reduced muscle fatigue resistance, as indicated by a rapid decline in 
power output and less fatigue endurance during repetitive contractions. The rapid 
decline in power output might reflect the high energetic demands of dynamic 
contractions and the impaired ATP-buffing capacity of hypoxic diaphragm, since 
muscle fatigue results from the imbalance of energetic supply and demand (49). The 
 
 74 
 
 
reduction in power output during repetitive contraction is the result of reduction in 
velocity, since force was clamped at 33.3% of Po. During hypoxic conditions the 
accumulation of intracellular metabolites, i.e., ADP and lactate, could be accentuated 
under repetitive isotonic contraction compared to hyperoxic conditions (2). The rise of 
ADP concentration has been shown to reduce the shortening velocity (2). Therefore, 
the sensitivity of muscle fatigue to hypoxia is greater than to hyperoxia.  
Our control data regarding Po, Vmax and the curvature of the force-velocity 
relationship correspond with published values for isolated diaphragm muscle at the 
same experimental set-up (21, 48), but differ from Morisson (36) and Metzger et al 
(33). Factors that contribute to this variability could include difference in the 
temperature, animal species and incubation time. For instance, Vmax was measured at 
36ºC by Morisson, whereas we performed all our experiments at 26º. Consequently 
Vmax was lower in our study. Metzger et al (33) reported a rise in Vmax and Po of the 
rat diaphragm with increasing temperature values. 
 
Effects of NO on isotonic contractile and fatigue properties during hypoxia. 
To date, no other study has evaluated the effect of NO on contractile properties in 
vitro in skeletal muscle during hypoxia, including in diaphragm, soleus and EDL 
muscles. We investigated the role of NO in isotonic contractile properties of the rat 
diaphragm in vitro during hypoxia. L-NMMA slowed the shortening-velocity over a 
wide range of loads during hypoxia. L-NMMA reduced Vmax by 28% of the rat 
diaphragm in vitro. The effects of L-NMMA were mediated by NO. Similar results 
were obtained with hemoglobin. Accordingly, both L-NMMA and hemoglobin 
depressed power generation as well during hypoxia. This finding is of physiological 
and functional significance, as power is considered as a more physiological estimation 
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of muscle performance in vivo than either force or velocity alone. The effects by L-
NMMA and hemoglobin on power generation are mainly due to a reduction of 
velocity, because power is the product of Po and velocity, and L-NMMA and 
hemoglobin did not affect Po. As mentioned previously velocity of shortening is 
determined by the rate of cross-bridge cycling (6), thus these findings indicate that 
endogenous NO plays a role in cross-bridge cycling during hypoxia, direct or indirect. 
The different effects of L-NMMA on Pt and shortening of velocity suggest that 
endogenous NO acts on multiple targets. The fact that the NO donor Sp-NO did not 
affect velocity of shortening during hypoxia, implies that diaphragm muscle might be 
able to adjust NO generation during active shortening. It has been shown that NO can 
adjust its own synthase by feedback in restricting NO production (8). 
A previous study reported that NOS inhibition depressed velocity of 
shortening and power generation of the rat diaphragm under hyperoxic conditions in 
vitro (36). The NOS inhibitor L-NNA at a concentration of 10 mM reduced Vmax and 
peak power ~16% and ~18%, respectively. But the reduction effect of the NOS 
inhibitor on isotonic contractility is more pronounced under hypoxic conditions (used 
in the present study, ~28% and ~39% in Vmax and peak power, respectively) than 
observed under hyperoxic conditions. A possible explanation is that generation of 
reactive oxygen species (ROS) is enhanced during hypoxia (13, 39). Therefore, the 
role of NO as an antioxidant is more important. It is also possible that hypoxia 
directly affects NO synthase. Previous studies showed that hypoxia impairs the SR 
Ca2+ re-uptake from the intracellular space (12, 52). This could result in an increase of 
[Ca2+]i levels (52) and may, in turn, activate NOS via Ca2+-dependent NOS isoforms. 
Hampl et al (19) showed that in pulmonary artery endothelium 10 min hypoxia (pO2 = 
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4.9 kPa) increases [Ca2+]i levels and NOS activity. Data regarding the effect of 
hypoxia on NO production in skeletal muscle are not available.  
The present study is the first one to demonstrate the effect of NO on isotonic 
fatigability in skeletal muscle in vitro. The diaphragm muscles were less able to 
sustain power generation after incubation with both L-NMMA and hemoglobin. 
These depression effects were persistent through the period of repetitive contractions. 
This result indicates that endogenous NO exerts a beneficial effect in the resistance of 
diaphragm muscle fatigue in vitro during hypoxia. As mentioned previously, either 
fatiguing stimulation alone, or hypoxia alone can enhance the formation of ROS (13, 
44). The combination of both conditions may cause more dramatic milieu changes. 
Data from our laboratory (21) showed that isotonic fatigue properties of the rat 
diaphragm are inhibited by antioxidants in vitro. This is in line with the observation in 
the present study. However, our data are in conflict with a previous study (17) using 
anaesthetized ventilated dogs, which found the protection from diaphragmatic fatigue 
by a NOS inhibitor L-NAME. Difference in the experimental set-up and species may 
explain these discrepancies. In contrast to a significant increase in isotonic fatigability 
by depletion of NO, addition of Sp-NO did not change fatigability during hypoxia. 
This implies that intracellular L-arginine content may be adequate for basal NO 
production during strenuous contractile activity under hypoxic conditions. It was 
found that the concentration of L-arginine in the tissue is high and could not be a 
limiting factor for NO synthase (30).  
The mechanism underlying the beneficial effect of NO on isotonic contractile 
and fatigue properties in vitro during hypoxia may relate to its antioxidant effect, 
perhaps either directly or indirectly. Biological activities of NO and ROS are strongly 
inter-dependent (28, 43). They and their redox-derivatives compete for the same metal 
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centers and thiol groups on the target protein (1, 43). At lower concentrations, NO 
prevent ROS-mediated oxidation on the Ca2+ release channels (RYR1) of the SR (1). 
Moreover, NO can protect cells against toxicity mediated by hydrogen peroxide 
(H2O2) (50). In addition, the net effect of NO depends on not only its relative 
concentration but also on the balance between the levels of NO and ROS (11).  
A potential issue is whether ROS generated from electrolysis plays a role in 
the observed effects of NO on isotonic contractile and fatigue properties in vitro 
during hypoxia. However, it is unlikely that ROS could be generated by electrolysis 
with the current applied to our system. Firstly, a study (44) using similar stimulus 
parameters showed that electrolytic superoxide anion radicals (O2-.) generation was 
not detectable after 1 h of repetitive stimulation (~ 250 mA/s). Secondly, 
theoretically, ROS generated by electrolysis, if present, could react with NO released 
from Sp-NO to form peroxynitrite, which has a strong pro-oxidant influence and 
could impair muscle performance (41, 47). However, the fact that addition of Sp-NO 
did not change isotonic contractile properties does not support this possibility. 
Conversely, generation of ROS is enhanced in cardiomyocytes during hypoxia (13), 
therefore, the fact that Pt was depressed with Sp-NO cannot rule out the possible 
influence of peroxynitrite formation in force generation during hypoxia.  
The mechanisms by which NO mediates its effect on contractile properties 
remain unclear. In contrast to smooth muscle, in skeletal muscle, the magnitude of 
cGMP-mediated changes is limited. NO may act directly on modulating regulatory 
proteins via redox effects (43). Thiol groups of the Ca2+ release channels of the SR are 
likely sites for such interaction (1, 22). Low concentrations of NO prevent channel 
opening from oxidation-induced activation, in this way reducing the rate of Ca2+ 
release. High concentrations promote opening of the RYR1 channels (1). In addition, 
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the effect of NO on the thiol groups of RYR1 could also be depended on local pO2 as 
well (15). The data from our own laboratory (20) also demonstrated that in 
permeabilized rabbit psoas muscle fibers an NO donor reduces Ca2+ sensitivity, which 
would contribute to a reduction of force. Andrade et al (3) also observed a reduction 
of Ca2+ sensitivity in single skeletal muscle from a mouse foot muscle, but force and 
maximal shortening velocity were largely unchanged. Reactive thiols present on the 
myosin head are another potential target. This modulation would reduce maximal 
force generation (40). 
In the present study the NOS activity was not determined in the diaphragm and 
other skeletal muscle. Previous studies showed that the NOS activity in the rat 
diaphragm was lower than in EDL muscle, since the activity of nNOS correlated 
strongly with type II fiber composition and type II composition of the diaphragm is 
lower compared to EDL muscle (26). Diaphragm muscles contract continuously, have 
a higher oxidative capacity and higher maximal blood flow. A lower NOS activity 
might be a match for these special functional and structure properties to down-
regulate muscle function in stress, or to integrate functional characteristics of 
contrasting fibers in a muscle bundle (10). 
 
Conclusions 
In summary, endogenous NO plays a protective role in hypoxia-mediated modulation 
of muscle contraction in the rat diaphragm in vitro. Depletion of NO reduced velocity 
of shortening, power generation and increased the fatigability of the rat diaphragm 
during hypoxia. Supplementation of exogenous NO with Sp-NO did not affect 
isotonic contractile and fatigue properties during hypoxia. The different effects of the 
NOS inhibitor on force generation and shortening of velocity suggest that NO acts on 
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multiple targets. The protective effect of NO on isotonic contractile and fatigue 
properties in vitro may relate to its antioxidant effect under hypoxic conditions.  
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Abstract 
Oxidants may play a role in hypoxia-induced respiratory muscle dysfunction. In the 
present study we hypothesized that hypoxia-induced impairment in diaphragm 
contractility is associated with elevated peroxynitrite generation. In addition, we 
hypothesized that strenuous contractility of the diaphragm increases peroxynitrite 
formation. In vitro force-frequency relation, isotonic fatigability and nitrotyrosine 
levels were assessed under hypoxic (Po2 ~ 6.5 kPa) and hyperoxic (Po2 ~ 88.2 kPa) 
control conditions and also in the presence of authentic peroxynitrite (60 min), epsilon 
(60 min) and the NOS inhibitor L-NMMA (90 min). Hypoxia-induced downward 
shift of the force-frequency relation was associated with elevated nitrotyrosine level 
in the diaphragm. During hypoxia, both ebselen and L-NMMA decreased 
nitrotyrosine levels, but did not affect force generation. Strenuous contractions 
impaired force generation, but did not affect nitrotyrosine levels in the diaphragm 
during hypoxia. But under hyperoxic conditions, fatiguing contractions were 
associated with elevated diaphragm nitrotyrosine levels. Under hyperoxic conditions 
exogenous peroxynitrite impaired force generation and increased nitrotyrosine level. 
These studies show that hypoxia-induced impairment in diaphragm contractility is 
associated with increased diaphragm protein nitration, but no causal relation was 
found between diaphragm nitrotyrosine formation and in vitro force generation.  
 
Introduction 
Hypoxia, a common feature in several respiratory diseases, including chronic 
obstructive pulmonary disease (COPD), adult respiratory distress syndrome (ARDS) 
and pneumonia, adversely affects respiratory muscle function. Diaphragm force 
generation is impaired and fatigability is increased under hypoxic conditions, both in 
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vitro and in vivo (4; 15; 25; 59). Impaired respiratory muscle function may result in 
ventilatory failure. The precise mechanisms involved in hypoxia-induced impairment 
in contractile performance are incompletely understood, but oxidative and nitrosative 
stress could be at play (20; 38).  
Nitric oxide (NO), a highly reactive second messenger, plays an important role 
in skeletal muscle physiology, including contractility (3; 29). It is produced by NO 
synthases (NOS)(35). The activity of the constitutive NOS isoforms (neuronal and 
endothelial NOS, nNOS and eNOS, respectively) is primarily regulated by 
intracellular Ca2+ concentration (34; 40). Hypoxia may impair intracellular Ca2+ 
homeostasis, which in turn could increase NO production by NOS. (13; 17; 60). Little 
information is available regarding the role of NO in muscle dysfunction during 
hypoxia. Previously, we have shown that inhibition of NOS improves rat diaphragm 
contractility under hypoxic conditions (58). It has been proposed that many of the 
deleterious effects of NO are mediated by the formation of peroxynitrite (22; 57), the 
reaction product of NO and superoxide anions (O2-) (7; 41). Several studies showed 
evidence of superoxide generation in the hyperoxic rat diaphragm (31; 43). 
Interestingly, hypoxia increases generation of reactive oxygen species in cardiac 
myocytes (14). We have shown that antioxidants improve diaphragm contractility 
under hypoxic conditions (20). It is unknown if peroxynitrite is generated in skeletal 
muscle and plays a role in impaired force generation induced by hypoxia. This is an 
important question, since peroxynitrite is a potent nitrating and oxidizing agent (41). 
It can result in cellular injury and cell death by causing oxidation of sulfhydryls, lipid-
peroxidation, and nitration of tyrosine residues in protein to form nitrotyrosine (7; 41).  
The first hypothesis of the present study was that hypoxia-induced impairment 
of in vitro force generation in the rat diaphragm is associated with increased 
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generation of peroxynitrite. To test this hypothesis we measured in vitro force 
generation of the rat diaphragm under hypoxic and hyperoxic conditions. After 
completion of contractile experiments, total nitrotyrosine formation was measured in 
these muscle bundles as a marker for peroxynitrite formation (7). In addition, the 
effects of exogenous peroxynitrite, the peroxynitrite scavenger ebselen and the NOS 
inhibitor L-NMMA were assessed  on in vitro contractility and nitrotyrosine 
formation of the rat diaphragm under hypoxic conditions. 
Increased muscle activity is associated with elevated generation of free 
radicals (31; 43). The fact that antioxidants improve diaphragm task endurance under 
hypoxic conditions (20) indicates that free radicals play a role in muscle contractility 
during hypoxia as well. However, it is unknown if diaphragm peroxynitrite formation 
increases during strenuous contractions under hypoxic conditions. The second 
hypothesis therefore was that strenuous work increases peroxynitrite formation in rat 
diaphragm muscle and that at a certain level of contractile failure the nitrotyrosine 
formation is similar during hypoxia and hyperoxia. To test this hypothesis, rat 
diaphragm muscle strips were fatigued to a predetermined level of contractile failure 
(20). At that level, nitrotyrosine formation was determined as a marker for generation 
of peroxynitrite.  
 
 87 
 
 
Methods 
Animal preparation 
Adult male outbred Wistar rats with a mean body weight of 351 ± 8 g were used. The 
rats were anaesthetized with pentobarbital sodium (70 mg/kg body wt ip). A 
tracheotomy was performed, a polyethylene cannula was inserted into the trachea, and 
the animals were mechanically ventilated with 100% O2. The diaphragm strips were 
prepared as described previously (20). Briefly, the diaphragm and adherent lower ribs 
were quickly excised after a combined thoracotomy and laparotomy, and was 
immediately submersed in cooled oxygenated (95% O2 and 5% CO2) Krebs solution 
at pH ~7.40. This Krebs solution consisted of 137 mM NaCl, 4 mM KCl, 2 mM CaCl2, 
1 mM MgCl2, 1 mM KH2PO4, 24 mM NaHCO3, and 7 mM glucose and 25 μM d-
tubocurarine (Sigma, Bornem, Belgium). From the central costal region of the 
hemidiaphragm a muscle strip was dissected along the parallel axis of the muscle fibers. 
Silk sutures were tied firmly to both ends of the muscle strip.  
 
Contractile measurements  
Contractile properties were measured as described previously (20). Briefly, the strips 
were mounted vertically in tissue baths containing Krebs solution bubbled with 95% 
O2-5% CO2 with a pH of 7.4. Temperature of the solution was maintained at 26ºC. 
The muscle was stimulated directly by using platinum plate electrodes placed in close 
apposition of the bundle. Stimuli were applied with a pulse-duration of 0.2 ms and 
train duration of 400 ms. Muscle preload force was adjusted until optimal fiber length 
(Lo) for maximal twitch force (Pt) was achieved. After 10 min thermo-equilibration 
baseline measurements were determined: force was measured at 1 Hz, 15 Hz, 30 Hz 
and 100Hz, train duration 250 ms, (Pt, P15, P30 and P0 respectively) with 2 min 
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interval. Next, gas mixture and Krebs solution were replaced by appropriate 
experimental conditions (see below). After 60 min or 90 min (see specific protocols) 
Pt, P15, P30 and Po measurement were repeated. In a subgroup isotonic fatigability was 
determined as published previously (20). Briefly, the load clamp level of the lever 
arm was set for maximum power output (assumed to be at 33.3% Po in both groups), 
and the muscle was stimulated at 100 Hz (330 ms train duration) every 2s. 
Stimulation continued until no muscle shortening could be observed, and this was 
defined as isotonic endurance time. After completion of contractile experiments pH, 
Po2 and Pco2 of the Krebs solution was measured using a bloodgas analyzer.  
 
Nitrotyrosine measurement  
Peroxynitrite formation was evaluated by detection of nitrotyrosine residues using 
western immunoblotting with a monoclonal anti-nitrotyrosine antibody (clone 1A6, 
Upstate Biotechnology Inc., Lake Placid, NY, USA) (5; 8). Crude muscle homogenate 
proteins (22 µg) were heated for 5 min at 95ºC in sample buffer, centrifuged for 5 min 
and then separated by electrophoresis (100 V for 1 h) on 8% sodium dodecylsulfate 
(SDS) polyacrylamide gels. High and low molecular weight standards of nitrotyrosine 
(Upstate Biotechnology) were run in parallel as positive control. Proteins were 
transferred electrophoretically (100 V, 300 mA for 1.5 h) to nitrocellulose 
membranes. The nitrocellulose membranes were subsequently incubated for 16 h at 
4°C with primary monoclonal antibodies raised against nitrotyrosine in 0.1 % bovine 
serum albumin (BSA) in phosphate-buffered saline with 0.1 % Tween-20 (= PBST). 
After three 10-min washes with PBST on a rotating shaker, the nitrocellulose 
membranes were incubated with a secondary antibody (polyclonal anti-mouse IgG 
horseradish peroxidase conjugated, Pierce, Rockford, IL, USA) for 1 h at room 
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temperature. The membranes were finally washed twice for 10 min with PBST. 
Afterwards, protein bands were visualized using an enhanced chemiluminescence 
detection kit (Amersham Biosciences Europe GmbH, The Netherlands). The blots 
were scanned with an imaging densitometer and optical densities (OD) of positive 
nitrotyrosine protein bands were quantified with GeneTools software (Syngene, U.K). 
Total nitrotyrosine OD was calculated for each samples by adding OD of individual 
positive protein bands. To confirm the specificity of antibody for nitrotyrosine, the 
antibody was incubated with 10 mM nitrotyrosine, or 1 mg/ml nitrated BSA, just prior 
to the membrane incubation, for 1 h at room temperature (32). Nitrated BSA was 
prepared by solubilizing 15 mg BSA in 10 ml of phosphate-buffered saline and 
incubation for 30 min at room temperature with 1 mM peroxynitrite. The nitration of 
the tyrosine residues in BSA was determined by the absorbance at 430 nm (27).  
  
Measurement of lipid-peroxidation 
Concomitant measurement of malondialdehyde (MDA) was made to determine 
whether the lipid-membranes or the protein components are the plausible target of 
peroxynitrite. MDA levels were assessed by high-performance liquid 
chromatography, as previously reported (56). Muscle samples of 40 mg were 
homogenized and centrifuged, and the supernatant were collected and stored on ice. 
Samples were hydrolyzed by boiling in diluted phosphoric acid. MDA, one of low-
molecular-weight end products formed via the decomposition of lipid- peroxidation 
products, was reacted with thiobarbituric acid (TBA) to form MDA-TBA adducts 
(24). The adduct was eluted from the column with methanol-phosphate buffer and 
quantified spectrophotometrically at 532 nm. HNE (4-hydroxynonenal) was 
determined as a second, chemically distinct measure for lipid-peroxidation.  22 µg 
 
 90 
 
 
crude muscle homogenate proteins were loaded on an 8% SDS/PAGE gel, separated 
by electrophoresis and transferred to nitrocellulose membranes for 1 h at 100V.  
Membranes were incubated with a HNE polyclonal antibody (Calbiochem, La Jolla, 
CA, USA) for 1 hour at room temperature. After three 10 min washes with PBST 
membranes were incubated with goat-antirabbit peroxidase conjugated (Pierce, 
Rockford, IL, USA) for 1 hour at room temperature. After washing with PBST protein 
bands were visualized as described in the nitrotyrosine paragraph. 
 
Experimental protocols  
EFFECTS OF HYPOXIA: In the first series of experiments, the effect of hypoxia on 
contractility, nitrotyrosine formation and tissue malondialdehyde (MDA) level was 
determined. After initial measurement of force-frequency characteristics, Krebs 
solution was replaced by fresh standard Krebs solution and gas mixture was 
maintained at 95% O2 and 5% CO2 (hyperox, n = 10) or changed to 95% N2 and 5% 
CO2 (hypox, n = 10). After 60 min, force-frequency relation was remeasured and 
subsequently bundles were blotted dry, quickly frozen in liquid nitrogen and stored at 
–80°C. From each group 5 bundles were used for measurement of nitrotyrosine, and 5 
bundles for MDA measurement. Experimental conditions may affect lipid-
peroxidation of the diaphragm muscle bundle. Therefore, in a subgroup, diaphragm 
muscle bundles were immediately after excision from the rat transferred into liquid 
nitrogen for later MDA measurement (Control, n = 5). 
EFFECTS OF FATIGUE: In the second series of experiments, the effects of 
fatiguing contractions on task endurance and nitrotyrosine formation were determined 
under hypoxic and hyperoxic conditions. After initial measurement of force frequency 
relation, Krebs solution was replaced by fresh standard Krebs solution and gas 
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mixture was either maintained at 95% O2 and 5% CO2 (hyperox-fatigue, n = 5) or 
changed to 95% N2 and 5% CO2 (hypox-fatigue, n = 5) for 60 min. After 
remeasurement of force-frequency relation, isotonic fatigue was determined as 
described above. After completion of contractile experiments, bundles were blotted 
dry and quickly frozen in liquid nitrogen and stored at -80°C for later nitrotyrosine 
analysis.  
EFFECTS OF PEROXYNITRITE AND EBSELEN: The effects of 
peroxynitrite (Upstate Biotechnology, The Netherlands) and ebselen (2-phenyl-1,2-
benzisoselemazol-3(h)-one, Calbiochem, The Netherlands) were determined on 
contractile properties and nitrotyrosine formation under hypoxic conditions. In pilot 
experiments we studied dose-response relation of peroxynitrite on Pt during 
hyperoxia. Diaphragm muscle bundles were treated with increasing concentrations of 
peroxynitrite: 10 µM, 100 µM, 250 µM, 500 µM and 1000 µM. Peroxynitrite was 
prepared according to the manufacturer’s instructions. Since 0.3 M NaOH serves as a 
diluent of peroxynitrite, pH in tissue bath was measured to detect any alkaline shift, 
which even in high peroxynitrite dose were less then 0.1 units. The half life of 
peroxynitrite is < 1.0 s at neutral to low pH (6), but is ~3.3 h in diluent 0.3 M NaOH 
(37). Although peroxynitrite has a short half-life time at physiological pH, the 
changes in skeletal- and smooth muscle function in vitro appeared to evolve long after 
1 h of exposure (28; 48). A single pulse of peroxynitrite was added in the bottom of 
the tissue bath. After 60 min Pt and Po were remeasured. The effects of peroxynitrite 
on Pt and Po were compared with that in standard Krebs solution during hyperoxia (n 
= 3 per group). From these experiments it appeared that 250 µM of peroxynitrite 
reduced Pt by ~35% from baseline (data not shown). Increasing peroxynitrite 
concentration further reduced Pt. Therefore, in subsequent experiments final 
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peroxynitrite concentration was 250 µM. Final concentration of ebselen was 50 µM 
(1; 33). Ebselen was dissolved in the lowest volume of DMSO, and consequently a 
final amount of DMSO in the tissue bath was 0.0009 v/v. In pilot studies we tested the 
effect of the solvents for peroxynitrite (0.3 M NaOH, equal volume, n = 4) and for 
ebselen (0.0009 v/v DMSO, n = 3) and also the effect of degraded peroxynitrite (n = 
4; Upstate Biotechnology, Veenendaal, the Netherlands) on in vitro force generation 
under hyperoxic conditions. An identical protocol was used as in the final studies. 
These data were compared with a control hyperoxic group. No differences in force 
generation were observed among these groups (data not shown). 
To study the effect of peroxynitrite and ebselen on contractility under hypoxic 
conditions, baseline measurements were determined as described above. 
Subsequently, Krebs solution was replaced by experimental Krebs solutions: standard, 
peroxynitrite 250 µM or ebselen 50 µM. After 60 min force frequency relation 
measurement was repeated and muscle bundles were quickly frozen as described 
above. Similar experiments were conducted under hyperoxic conditions: Accordingly, 
in this series of experiments six groups of rats were studied: hypox (n = 10), hypox-
peroxynitrite (n = 10), hypox-ebselen (n = 10), hyperox (n = 10), hyperox-
peroxynitrite (n = 10), hyperox-ebselen (n = 10). From each group, 5 bundles were 
used for measurement of nitrotyrosine and 5 bundles for MDA concentration. HNE 
was determined as a second measure for lipid-peroxidation in three groups of bundles: 
hyperox, (n = 10), hypox, (n = 7) and hypox-peroxynitrite, (n = 10).  
EFFECTS OF NOS INHIBITION: Since peroxynitrite is generated from 
superoxide and NO, inhibition of NO synthesis is expected to reduce peroxynitrite 
formation. Recently, we have shown that the NOS inhibitor L-NMMA (30 µM for 90 
min) increases force generation of the rat diaphragm under hypoxic conditions. 
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Accordingly, in the fourth series of experiments the effects of L-NMMA (AcOH, 
Calbiochem, Breda, The Netherlands) on in vitro force generation and diaphragm 
nitrotyrosine formation were assessed. After initial force – frequency measurements (Pt, 
P10, P30, Po), gas mixture was changed to hypoxia (to 95% N2 and 5% CO2) and Krebs 
solution was replaced by fresh standard Krebs solution (Hypox, n = 6) or Krebs solution 
containing 30 µM L-NMMA (Hypox-L-NMMA, n = 6). After 90 min force frequency 
measurements were repeated. Subsequently, bundles were blotted dry and quickly frozen 
for nitrotyrosine analysis.   
 
Data treatment and statistics 
After completion of contractile experiments, the length and dry-weight of the 
diaphragm muscle bundle were measured. Cross-sectional area (CSA) was calculated 
by dividing diaphragm strip weight (g) by strip length (cm) times specific density 
(1.056). Force is expressed per cross sectional area in N/cm2. Muscle shortening 
velocity in fatigue experiments was calculated as the change in muscle length during a 
30 ms period and expressed as muscle lengths per s (L0/s). To eliminate the effect of 
muscle compliance, the time window for shortening velocity measurements was set to 
begin 10 ms following the first detectable change in length. Data are presented as 
means ± standard error (SE). Differences in single baseline contractile properties, 
bundles dimensions, gas pressure and nitrotyrosine levels among the experimental 
groups were analyzed with either Student T test or one-way ANOVA and if appropriate, 
Student-Newman-Keuls (SNK) post hoc testing. Parameters requiring repeated 
measures over time (force frequency, fatigue) were estimated using repeated 
measurement models, if appropriate, SNK post hoc testing.  Statistical analysis was 
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performed with the SPSS package version 12.0 (SPSS, Chicago, IL). Comparisons 
were considered significant at P < 0.05.  
 
Results 
Gas tension analysis, muscle strip dimensions 
Perfusion of the tissue baths with the hypoxic gas mixture reduced Po2 of the Krebs 
solution to ~ 6.5 ± 0.2 kPa, as compared with 88.2 ± 1.6 kPa in the hyperoxic groups 
(P < 0.001). The pH and Pco2 of the tissue baths were not significantly different 
between hypoxic and hyperoxic groups (pH: 7.40 ± 0.01 vs. 7.38 ± 0.02; Pco2: 4.6 ± 
0.1 kPa vs. 4.8 ± 0.4 kPa in hypoxic and hyperoxic groups, respectively, P > 0.05).  
No difference was observed in muscle strip dimensions among all 
experimental groups. Average muscle strip weight was 44.2 ± 1.0 mg, and strip length 
at Lo was 19.0 ± 0.3 mm.  
 
Contractile studies 
HYPOXIA: initial force frequency relation was not different between hypox and 
hyperox (P > 0.05) and averaged 7.4 ± 0.2, 11.8 ± 0.5, 15.1 ± 0.6 and 16.3 ± 0.6 n/cm2 
for Pt, P15, P30 and Po respectively. Hypoxia resulted in a significant downward shift 
of the force frequency curve as compared with hyperoxia (Fig 1, P < 0.001).  
FATIGUE: Repetitive contractions resulted in progressive loss of power, 
which was more rapid during hypoxia then during hyperoxia (fig. 2A, P < 0.05). Time 
to task failure was significantly reduced by hypoxia (Fig 2B, P < 0.005). 
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Figure 1.  Force frequency relation in the rat diaphragm after 60 min in either hypoxia (hypox) or 
hyperoxia (hyperox). Hypoxia shifted the force frequency curve downwards * P < 0.001 compared to 
hyperox 
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Figure 2 A: Power production during repetitive isotonic contractions in the rat diaphragm. Fatigue 
rate was significantly higher in hypox than in hyperox (P < 0.05). B: Mean isotonic fatigue endurance 
in the rat diaphragm under hypoxic and hyperoxic conditions. * P < 0.01 vs. hyperox 
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PEROXYNITRITE AND EBSELEN: Under hypoxic conditions, neither 
peroxynitrite, nor ebselen affected the force – frequency relation (Fig 3A, P > 0.05). 
However, under hyperoxic conditions, peroxynitrite resulted in a significant 
downward shift of the force – frequency curve (Fig 3B, P < 0.01).  If force generation 
after exposure to peroxynitrite is normalized for its respective control, still the effect 
under hyperoxic conditions is much more prominent: Relative force generation in 
hypox-peroxynitrite vs. hypox was 78%, 80%, 77% and 83% for Pt, P15, P30 and Po 
respectively. Relative force generation in hyperox-peroxynitrite vs. hyperox was 66%, 
68%, 65% and 60% for Pt, P15, P30, and Po respectively. Ebselen did not affect force 
frequency relation under hyperoxic conditions (Fig 3 A/B, both P > 0.05). 
L-NMMA: Both in hypox and hypox-L-NMMA a significant depression in 
force frequency relation was observed after 90 min incubation (Fig 4A, P < 0001). 
When expressed as percentage of initial force, L-NMMA tended to improve force 
frequency relation under hypoxic conditions (Fig 4B, P = 0.095).  
 
Nitrotyrosine formation in the rat diaphragm 
HYPOXIA. Monoclonal anti-nitrotyrosine antibody detected roughly eight nitrated 
protein bands in diaphragm of hyperox, with molecules masses ranging from ~ 230-
28 kDa (Fig 5B). Nitrotyrosine protein band OD in control diaphragm was similar to 
hyperox (P > 0.05, fig. 5A). Hypoxia significantly increased diaphragm nitrotyrosine 
level (P < 0.001, Fig. 5A). Roughly, additional nitrotyrosine proteins bands were 
detected at 295 and 243 kDa in the hypox group. Nitrotyrosine OD at 150 kD was 
increased in hypox (P < 0.01 vs. hyperox).  
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Figure 3. Force-frequency relation of the rat diaphragm after 60 min in experimental Krebs solution. 
A: Under hypoxic conditions, neither peroxynitrite nor ebselen affected force frequency relation (P > 
0.05). B: Under hyperoxic conditions, peroxynitrite shifted the force frequency relation downwards, 
but force-frequency relation was not affected by 60 min exposure to ebselen (P > 0.05).  
*P < 0.01 vs. hyperox 
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Figure 4. Effect of NOS inhibitor L-NMMA on force frequency relation under hypoxic conditions. 
A. Solid symbols represent initial force generation, open symbols force frequency relation after 90 min 
in experimental conditions; squares represent hypox, circles hypox-L-NMMA. Initial measurement of 
force generation was not different between hypox and hypox-L-NMMA. Also, 90 min incubation with 
L-NMMA did not significantly affect decline in force under hypoxic conditions. B. When normalized 
for initial force, L-NMMA tended to increase force generation (P = 0.095 hypox vs. hypox- L-NMMA, 
n = 6 per group). 
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FATIGUE: At the time of task failure nitrotyrosine OD was not significantly 
different between hypox-fatigue and hyperox-fatigue. (P > 0.05, Fig 6A), nor between 
hypox and hypox-fatigue. However, under hyperoxic conditions, fatiguing 
contractions significantly increased nitrotyrosine OD (Fig 6, P < 0.05, hyperox vs. 
hyperox-fatigue). Interestingly, after fatiguing contractions under hyperoxic 
conditions nitrotyrosine protein expression at 295 and 243 kDa resembled the hypox 
pattern.  
 PEROXYNITRITE AND EBSELEN: Peroxynitrite exposure under hypoxic 
conditions did not affect total nitrotyrosine OD (P > 0.05, hypox vs. hypox-
peroxynitrite, Fig 7A). Ebselen reduced total nitrotyrosine OD under hypoxic 
conditions (P < 0.01, hypox vs. hypox-ebselen), although not to completely to the OD 
of hyperox group. Peroxynitrite significantly increased nitrotyrosine OD under 
hyperoxic conditions (P < 0.05, hyperox vs. hyperox-peroxynitrite, Fig 7B). With 
peroxynitrite an additional protein band was detected at 325 kD (Fig 7C). Also, 
nitrotyrosine OD at 150 kD was higher than that in diaphragm of hyperox group (P < 
0.05). Ebselen did not affect nitrotyrosine OD of the diaphragm under hyperoxic 
conditions.  
L-NMMA: Under hypoxic conditions, L-NMMA significantly reduced nitrotyrosine 
OD in rat diaphragm muscle (Fig 8, P < 0.05).  
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Figure 5 A: Total OD’s for nitrotyrosine bands of rat diaphragm immediately removed from animal 
(control), after 60 min under hyperoxic conditions (hyperox) or after 60 min under hypoxic conditions 
(hypox). Hypoxia significantly increased rat diaphragm nitrotyrosine level. * P < 0.001 compared to 
control, † P < 0.001 compared to hyperox B: Representative immunoblots of rat diaphragm 
homogenates from control (1), hyperox (2) and hypox (3) groups. Note the increased OD under 
hypoxic conditions, but also the appearance of high molecular bands (> 200 kDa) not observed in 
hyperox. Nitrotyrosine level was detected with monoclonal anti-nitrotyrosine antibodies (see methods). 
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Figure 6 A. Effect of strenuous contractions of the rat diaphragm in vitro on total nitrotyrosine OD’s. 
Under hypoxic conditions strenuous contractions did not affect nitrotyrosine OD. However, strenuous 
contractions under hyperoxic conditions significantly increased diaphragm nitrotyrosine OD. * P < 
0.001 compared to hypox, † P < 0.05 compared to hyperox B. Representative immunoblots of rat 
diaphragm homogenates form hypox (1), hyperox (2), hypox-fatigue (3) and hyperox-fatigue (4).  
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Figure 7 Effects peroxynitrite or ebselen exposure (60 min) on rat diaphragm total nitrotyrosine OD.  
A: Peroxynitrite did not affect nitrotyrosine OD of the diaphragm under hypoxic conditions. However, 
after 60 min exposure to ebselen, nitrotyrosine level of the diaphragm was significantly reduced. * P < 
0.01 vs. hypox. B: Under hyperoxic conditions, 60 min incubation with peroxynitrite significantly 
increased nitrotyrosine OD. Instead, ebselen did not affect nitrotyrosine level under hyperoxic 
conditions.  † P < 0.05 vs. hyperox. C: Representative immunoblots of rat diaphragm homogenates 
under different experimental conditions, for details see methods. Hyperox (1), hyperox-peroxynitrite 
(2), hyperox-ebselen (3), hypox (4), hypox-peroxynitrite (5) and hypoxia-ebselen (6).  D: Selectivity of 
the monoclonal antibody. Preincubation of the anti-nitrotyrosine antibody with nitrated bovine serum 
albumin resulted in near disappearance of the positive nitrotyrosine bands in hyperox diaphragm 
homogenates (1) and homogenates of diaphragm bundles exposed to peroxynitrite (2).
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Figure 8 Effects of NOS inhibition with L-NMMA (30 µM, 90 min) on rat diaphragm muscle 
nitrotyrosine OD under hypoxic conditions. A. Total nitrotyrosine OD was significantly lower in the 
presence of L-NMMA. *P < 0.05 
B. Representative immunoblot of rat diaphragm homogenates showing reduced nitrotyrosine staining 
in the presence of L-NMMA. 
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Lipid-peroxidation 
Hypoxia did not increase diaphragm muscle lipid-peroxidation as indicated by the 
lack of effect on MDA (P > 0.05 hypox vs. hyperox, n = 5, Fig 9). Neither 
peroxynitrite, nor ebselen did affect MDA under hypoxic or hyperoxic conditions (P > 
0.05, Fig 9 A/B). HNE, a chemically distinct marker for lipid-peroxidation was 
determined, to confirm the absence of lipid-peroxidation under hypoxic conditions. In 
line with the MDA data, no significant differences were observed in HNE between 
hyperox, hypox and hypox-peroxynitrite (P > 0.05, Fig 9 C/D).    
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Figure 9 Lipid peroxidation in rat diaphragm. For details see text.  Malondialdehyde (MDA) was 
used as a marker for lipid peroxidation. Neither peroxynitrite, nor ebselen affected rat diaphragm 
muscle lipid peroxidation under hypoxic (A) or hyperoxic conditions (B) 
C. Hydroxynonenal (HNE), a chemically distinct marker for lipid peroxidation, was used to verify 
MDA data. However, no differences were observed in HNE due to hypoxia or peroxynitrite treatment.  
D. Representative immunoblot of rat diaphragm homogenates. Similar patterns were observed in 
hyperoxia (1), hypoxia (2) and hypoxia-peroxynitrite (3).  
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Discussion 
 
The main findings of the present study are that (1) severe hypoxia enhances 
nitrotyrosine formation in rat diaphragm, (2) hypoxia-induced elevation in diaphragm 
nitrotyrosine levels can be (partially) prevented by peroxynitrite scavenging or NOS 
inhibition, (3) under hypoxic conditions NOS inhibition tends to improve in vitro 
force generation, (4) exogenous peroxynitrite increases nitrotyrosine levels and 
impairs force generation of the rat diaphragm under hyperoxic conditions, (5) 
fatiguing contractions enhance nitrotyrosine levels in the hyperoxic diaphragm.  
 
Methodological considerations 
Ebselen, an seleno-organic compound (45) was used as a peroxynitrite scavenger. It 
exhibits a marked thiol-dependent glutathione peroxidase-like activity and especially 
displays anti-oxidant activity in the micromolar range (39; 45). It acts as a singlet 
oxygen quencher (39; 45) and peroxynitrite scavenger (11; 12; 33). The reaction of 
ebselen with peroxynitrite is a simple oxygen atom transfer and depends on pH and 
temperature (36). As a lipid-soluble compound, it is likely to exert its effect 
intracellular (45).  
 Based on dose response studies, peroxynitrite at 250 µM was used (see 
methods). It is unknown if this concentration is within limits of intracellular 
concentration during (patho-) physiological conditions. Due to the extreme short half-
life of peroxynitrite, actual concentration with muscle fibers is unknown. Although 
NO release has been measured from intact skeletal muscle tissue in vitro (3), no data 
are available on NO concentrations within the subcellular compartments. This is 
relevant because within muscle fibers NOS expression is not uniform (29; 30), 
suggesting that localized areas of higher NO concentration may exist. Also, localized 
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areas of high superoxide generation may exist within muscle fibers. Therefore, 
measuring average concentration of NO, superoxide or peroxynitrite does not provide 
accurate information regarding maximal concentration within muscle fibers. 
 Nitration of protein tyrosine residues results in the formation of 3-
nitrotyrosine, i.e. (7; 16). In the present study nitrotyrosine formation was detected 
using a monoclonal antibody that is known to have high specificity (7). Although 
other nitrogen centered oxidants such as nitrogen dioxide and acidified nitrite may 
result in nitrotyrosine formation, this is unlikely to happen in vivo, since the 
concentration of nitrogen dioxide and nitrite present in vivo are far lower than 
necessary to cause significant nitration (7). It has been proposed that nitrogen dioxide 
radical production by myeloperoxidase may be an important source for nitrotyrosine 
formation in vivo (21). However, the current studies were performed in isolated 
muscle bundles that do not contain myeloperoxidase, ruling out contribution of this 
pathway for nitrotyrosine formation. 
The effect of hypoxia on nitrotyrosine formation of the diaphragm muscle was 
investigated in vitro. Clearly, this might not completely represent the effects of 
hypoxia on nitrotyrosine formation in vivo. However, a limitation of in vivo studies 
would be that hypobaric hypoxic environment increases work of breathing, which will 
enhance generation of oxidants in the diaphragm (31). The model used in the present 
study permits investigating the effects of hypoxia alone on muscle nitrotyrosine level.  
  
Hypoxia and skeletal muscle function 
Previously, we have discussed the severity of hypoxia as used in the present study 
(Po2 ~6.5 kPa) (50). This should be considered as severe hypoxia, especially because 
under present experimental conditions oxygenation of the muscle solely depends on 
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diffusion of O2 into the central region of the muscle bundle. Therefore, the average 
Po2 of the muscle will be well below 6.5 kPa. Several studies have shown that 
hypoxia impairs diaphragm muscle function (15; 20; 50; 51). Recently, we have 
shown that under resting conditions hypoxia mainly affects isometric contractile 
properties with no effect on shortening velocity (20). For this reason we focused on 
isometric contractile properties in non-fatiguing experiments. The precise 
mechanisms of hypoxia-induced impairment in muscle contractility are unknown. 
Several recent studies indicate that free radicals may be at play (20). We have recently 
summarized current knowledge on the role of hypoxia in muscle dysfunction (20).  
 
Nitrotyrosine in skeletal muscle 
Peroxynitrite is generated by reaction of superoxide with NO (7). This reaction rate is 
approximately six times faster than the scavenging of superoxide with superoxide 
dismutase (7), one of the physiological scavengers of superoxide. In line with 
previous observations (5; 52), the present study shows nitrotyrosine in the rat 
diaphragm muscle under baseline conditions. The molecular weight of the molecules 
nitrated in the present study is in line with observations by Vassilakopoulos (52), but 
higher then reported by Barreiro (5). The discrepancy between these latter two studies 
(5; 52) is unclear. 
Nitrotyrosine level can be increased under certain (patho)-physiological 
conditions. Barreiro et al (5) showed that LPS-induced sepsis increased nitrotyrosine 
formation in rat diaphragm, especially in the cytosolic fraction. In addition, exercise 
training increases gastrocnemius nitrotyrosine level (52). Our data show that acute 
hypoxia increases diaphragm muscle nitrotyrosine level. Elevated generation of NO 
and / or superoxide may enhance peroxynitrite formation. It has been shown that in 
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cardiomyocytes generation of oxidants is increased depending on the degree of 
hypoxia, the lower the Po2, the higher oxidant generation (14). In addition, 
antioxidants reduce fatigability of the rat diaphragm under hypoxic conditions, 
indicating that reactive oxygen species affect force generation under hypoxic 
conditions (20). Little is known about the effects of acute hypoxia on NOS regulation 
or the rate of NO generation in skeletal muscle. Sixty days of hypobaric hypoxia 
increases eNOS and nNOS expression and activity in rat diaphragm muscle, but 
prolonged (9 mo) exposure declined NOS activity and expression (26).  
Hypoxia increased nitrotyrosine OD of protein bands already present under 
hyperoxic conditions, but also resulted in the appearance of additional protein bands, 
for instance at ~295 and ~243 kDa (fig 5B). These same bands appeared muscle 
bundles subjected to fatiguing contractions under hyperoxic conditions (fig 6B). The 
nature of these proteins is unknown, but potential targets for peroxynitrite include 
myosin, actin and troponin I, which have tyrosine groups that can be nitrated (7; 23). 
Peroxynitrite can also affect calcium homeostasis by inactivating Ca2+-ATPase (53-
55), although data are conflicting (47). Studies with cultured cardiac myocytes 
revealed that plasma membrane proteins and myofibrillar creatine kinase are potential 
targets for peroxynitrite as well (23; 37). In addition, mitochondria potentially provide 
an abundant source of superoxide, and high concentrations of NOS are localized to 
mitochondria in skeletal muscle. Consequently, peroxynitrite may reach high 
concentrations in mitochondria, affecting nitration of mitochondrial proteins, thereby 
impair mitochondrial function (10).  
Under hypoxic conditions, incubation with peroxynitrite did not increase 
diaphragm nitrotyrosine formation. We are not aware of studies showing that half-life 
time or reactivity of exogenous peroxynitrite depends on O2 tension. Theoretically, 
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peroxynitrite reactivity towards tyrosine could depend on O2 tension. Indeed, recently, 
it has been shown that the effects of NO on muscle contractility depend on muscle Po2 
(18). The Po2 dependency for peroxynitrite in skeletal muscle is not known. A more 
likely explanation for the inability of peroxynitrite to enhance nitrotyrosine levels 
under hypoxic conditions is that all highly reactive tyrosine groups were already 
nitrated. Indeed, it has been suggested that not all tyrosine groups in biological 
environment are equally susceptible to nitration (16; 46). Protein characteristics, such 
as the location of tyrosine on a loop structure, its association with neighboring 
negative charge, determine susceptibility to nitration by peroxynitrite. This could also 
explain the absence of elevated protein nitration after strenuous contractions under 
hypoxic conditions. In hyperoxia, strenuous contractions significantly increase protein 
nitration, but to a level approximately equal to protein nitration under baseline 
hypoxic conditions (fig 6).  
 
Functional consequences of nitrotyrosine formation in skeletal muscle 
Nitrotyrosine formation has been suggested as just ‘footprints’ of peroxynitrite 
formation. However, evidence is accumulating that nitrotyrosine formation is a 
posttranslational mechanism for altering protein function (16) and thereby muscle 
contractility. The present study is the first to describe the relation between 
nitrotyrosine levels and in vitro contractility. Under hypoxic conditions the reduction 
in contractility was accompanied by enhanced nitrotyrosine levels. A similar pattern 
was observed after peroxynitrite exposure under hyperoxic conditions. The 
peroxynitrite-induced decrease in force generation is in line with previous 
observations (48). Interestingly, Supinski et al (48) found that peroxynitrite impaired 
force generation in skinned single skeletal muscle fibers, indicating a direct effect on 
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contractile proteins. Reducing nitrotyrosine levels using the peroxynitrite scavenger 
ebselen, did not improve contractility in the present study. However, it should be 
noted that although ebselen significantly reduced nitrotyrosine level under hypoxic 
conditions, levels were still higher compared to hyperoxia (fig 7A/B). Thus the 
inhibition of nitrotyrosation may have been too modest to exert an effect on force 
generation. Alternatively, it should be kept in mind that ebselen is not solely a 
peroxynitrite scavenger, but also scavenges superoxide (see ‘methodological 
considerations), which may modulate force generation via different pathways. Also, 
L-NMMA significantly reduced hypoxia-induced nitrotyrosine levels, but the effects 
on contractility were modest, if present at all (Fig 4B, P = 0.095, n = 6). Together, no 
causal relationship seems to exist between total nitrotyrosine level in diaphragm 
muscle and contractility. However, this is not surprising, since the effect of protein 
nitration on contractility depends on the final effect of all proteins nitrated. 
 The mechanisms of increased peroxynitrite formation under hypoxic 
conditions have not been investigated. It can be speculated that elevated generation of 
peroxynitrite is the result of hypoxia-induced inflammatory response. Evidence is 
emerging that hypoxia induces expression of cytokines such as tumor necrosis factor 
alpha (TNF-α) both in vitro (9; 18) and in vivo (49). In turn, TNF-α has been shown 
to increase oxidant levels in diaphragm muscle fibers (44) and also increase the 
generation of NO in peripheral skeletal muscle (2). However, whether the hypoxia-
induced elevation in nitrotyrosine formation in skeletal muscle is related to the 
activation of proinflammatory cytokines remains to be investigated. 
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Clinical relevance 
Hypoxia is a common feature in various pulmonary diseases including COPD, 
pneumonia and ARDS. The adverse effects of hypoxia on respiratory muscle function 
are commonly recognized, but relatively little is known about the underlying 
pathophysiology. Recent studies have shown that oxidants play a prominent role in 
muscle physiology at different steps in excitation-contraction coupling (for review 
e.g.(19; 42)). Recent studies indicate that oxygen free radical scavengers improve 
muscle endurance under hypoxic conditions. Whereas hypoxia may directly increase 
oxidant generation by the respiratory muscles, the hypoxia-induced elevated work of 
breathing will further enhance oxidant generation by the respiratory muscles. Further 
understanding of the role of oxidants in respiratory muscle function is needed in order 
to develop successful strategies for preventing hypoxia induced respiratory muscle 
failure.  
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Abstract 
Nitric oxide (NO) has been recognized as a neurotransmitter. Little is known about 
the role of NO in hypoxia-induced neuromuscular transmission failure of rat 
diaphragm in vitro. The effects of the NO synthase (NOS) inhibitor nomega-nitro-L-
arginine (L-NNA, 1 mM) and the NO donor Spermine NONOate (Sp-NO, 1 mM) 
were evaluated on neurotransmission failure during non fatiguing and fatiguing 
contractions of the rat diaphragm under hypoxic (Po2 ~ 5.8 kPa) and hyperoxic 
conditions (Po2 ~ 64.0 kPa). Hypoxia impaired force generated by both muscle 
stimulation at 40 Hz (P40M) and by nerve stimulation at 40 Hz (P40N). The effect of 
hypoxia in the latter was more pronounced. L-NNA increased P40N whereas Sp-NO 
decreased P40N during hypoxia. In contrast, neither L-NNA nor Sp-NO affected P40N 
during hyperoxia. Besides, L-NNA only slightly reduced NTF during fatiguing 
contractions under hyperoxic conditions. Consequently, neurotransmission failure 
assessed by comparing force loss during repetitive nerve simulation and superimposed 
direct muscle stimulation was more pronounced in hypoxia, which was alleviated by 
L-NNA and aggravated by Sp-NO. We conclude that NO is involved in hypoxia-
induced NTF in the rat diaphragm  in vitro.  
 
 
Introduction 
Respiratory muscle fatigue, especially that of the diaphragm, has been recognized as a 
possible contributor to the development of respiratory failure, for instance in patients 
with chronic obstructive pulmonary disease (COPD) (24). Diaphragm fatigue may be 
the result of a failure of the muscle tissue itself to generate force (contractile fatigue) 
and/or failure in neuromuscular transmission (3). In vitro studies indicate that the 
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contribution of neurotransmission failure to muscle fatigue ranges from 18% (17) to 
as much as 75% (1). The importance of neuromuscular transmission failure as a site 
for the development of respiratory failure has also been demonstrated in intact 
animals (6).  
Hypoxia, a common feature in several respiratory diseases including COPD, 
adult respiratory distress syndrome and pneumonia, impairs neuromuscular 
transmission in the rat diaphragm (5). However, little is known about the underlying 
mechanisms of hypoxia-induced neurotransmission failure in the respiratory muscles. 
In skeletal muscle, nitric oxide (NO) plays a role in the regulation of neural 
transmission (30; 45). Skeletal muscle is a major source for NO in the body (31) and 
neuronal NO synthase (nNOS) is present in high concentrations at the post-synaptic 
surface of the neuromuscular junction of both fast- and slow-twitch fibers (8; 21). 
Furthermore, NO appears to influence acetylcholine release from pre-synaptic 
terminals in several types of neuromuscular junction models, including skeletal 
muscle (30; 36) Recently, we have shown that hypoxia-induced impairment in rat 
diaphragm contractile performance is associated with elevated peroxynitrite formation 
in the diaphragm muscle indicating that reactive nitrogen species are involved in force 
modulation under hypoxic conditions (46). However, the role of reactive nitrogen 
species in neuromuscular transmission failure under hypoxic conditions has not been 
studied. Accordingly, it could be speculated that NO plays a role in neuromuscular 
transmission under hypoxic conditions, given the fact that 1) NOS is highly expressed 
at the neuromuscular junction, 2) hypoxia enhances the generation of reactive 
nitrogen species in the rat diaphragm and 3) NO affects acetylcholine release at 
neuromuscular junction. Accordingly, in the present study we evaluated the role of 
NO in hypoxia-induced neuromuscular transmission failure of the rat diaphragm 
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during non-fatiguing and fatiguing stimulations. We hypothesized that reactive 
nitrogen species impair neuromuscular transmission of the diaphragm under hypoxic 
conditions. In order to test this hypothesis we evaluated the effects of the NOS 
inhibitor N-nitro-L-arginine (L-NNA) and the NO donor Spermine NONOate (Sp-
NO) on rat diaphragm neuromuscular transmission during non-fatiguing and fatiguing 
contractions under hypoxic conditions. These effects were compared with responses 
under hyperoxic conditions.  
 
Materials and Methods 
General procedures  
The study was reviewed and approved by the local animal ethics committee. Adult 
male outbreed Wistar rats with mean body weight of 378 ± 6 g were used. The 
animals were housed in a specific pathogen-free unit and fed ad libitum. The rats were 
anesthetized with pentobarbital sodium (70 mg/kg body wt ip) and mechanically 
ventilated with 100% O2. To this end a tracheotomy was quickly performed and a 
polyethylene cannula was inserted into the trachea. The nerve-diaphragm preparation 
was prepared as described previously (12; 16; 20). Briefly, the diaphragm and 
adherent lower ribs were quickly excised. The right hemidiaphragm was excised 
along with its rib insertions, central tendon, and phrenic nerve. The phrenic nerve was 
not dissected free from the inferior vena cava before excision to minimize the risk of 
nerve injury. The nerve-diaphragm preparation was immediately submersed in cooled 
oxygenated Krebs solution at a pH ~ 7.40. This Krebs solution consisted of 137 mM 
NaCl, 4 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 1 mM KH2PO4, 24 mM NaHCO3, 
7 mM glucose. From this preparation small muscle-nerve strips were dissected to 
assess neuromuscular transmission failure. 
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Assessment of neuromuscular transmission failure 
The procedures for assessing neuromuscular transmission failure in the rat diaphragm 
have been described previously. (20; 40). The muscle nerve strip was mounted vertically 
and suspended in a flow through chamber containing Krebs solution, maintained at 26 
°C, and perfused with a 95% O2-5% CO2 mixture. The costal margin of the muscle 
strip was clamped to a micromanipulator for adjustment of muscle length. The central 
tendon of the diaphragm was attached to a force transducer (Cambridge Technologies, 
model 308B, Cambridge, USA). 
 The Cambridge system was controlled by using Poly 5.0 software (Inspektor 
Research Systems bv, The Netherlands). The muscle was stimulated directly by using 
platinum plate electrodes placed in close apposition on either side of the muscle. 
Rectangular current pulses (2 ms) were generated by a stimulator (ID Electronics, 
University Medical Centre Nijmegen) activated by a personal computer. Phrenic 
nerve stimulation was achieved by 0.2 ms duration pulses delivered through a suction 
electrode. In both direct muscle and phrenic nerve stimulation, stimulus intensity was 
increased until maximal twitch force was obtained. To ensure supramaximal 
stimulation, the muscle strips were stimulated 1.25 times the current needed for 
maximal activation (~ 200-250 mA). Muscle preload force was adjusted using the 
micromanipulator until optimal fiber length (Lo) for maximal twitch force was 
achieved.  
After 15 min of thermo-equilibration, force generated at 40 Hz via the phrenic 
nerve (P40N) was measured twice, with a 2 min interval. Next, force generated at 40 
Hz by direct muscle stimulation (P40M) was measured, to obtain a measure of the 
quality of the preparations. A stimulation frequency of 40 Hz was chosen because 
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diaphragm motor units typically fire at frequencies ranging from 20 to 40 Hz when 
breathing is stimulated by hypoxia (34; 42). Subsequently, the perfusion of the tissue 
bath was either maintained at hyperoxia (95% O2 - 5% CO2) or switched to hypoxia 
(95% N2 - 5% CO2); the Krebs solution was replaced by the experimental Krebs 
solutions (see treatment groups). After 30 min of incubation, P40N and P40M were 
measured again to determine the effects of the intervention.  
A Po2 of ~ 5.8 kPa was chosen to represent hypoxia. Although this Po2 would 
not be regarded severe hypoxia in vivo (4), where O2 is carried to the muscle cells by 
the surrounding capillaries, it is considered as severe hypoxia in our in vitro 
preparation as the O2 has to reach the inner parts of the preparation via diffusion from 
the tissue bath surrounding, but not penetrating, the muscle strip (38). In addition, it 
has been found that 21% O2 (in solution) resulted in lower than normal membrane 
potentials that were detectable only in the outermost layers of the isolated rat 
diaphragm (9). Thus, the degree of tissue hypoxia should be considered as severe 
under these experimental conditions (44). Furthermore, in pilot experiments we found 
that a further reduction in Po2 to ~4.4 kPa for 30 min dramatically reduced force 
generated by nerve stimulation (Fig 1, n = 4). Under those circumstances additional 
contractile experiments lack physiological relevance.  
The relative contribution of neuromuscular transmission failure to diaphragm 
fatigue was estimated by superimposing direct muscle stimulation on repetitive 
stimulation of the phrenic nerve at 40 Hz for a 2.1 min period (20). Both nerve and 
muscle stimulations were presented in 330-ms duration trains.  The muscle strip was 
activated once every second for 2.1-min via the phrenic nerve, but every 14th and 15th 
s via direct muscle stimulation (Fig. 2). 
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Figure 1. Pilot study showing the effect of bathing medium Po2 on force generated by direct muscle 
stimulation at 40 Hz (P40M) and or nerve stimulation (P40N) was investigated in pilot experiments. 
P40M and P40N were determined before and 30 min after switching to bathing medium with different 
Po2. 
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Figure 2. Representative figure showing the fatigue protocol, in this case under hyperoxic conditions. 
Absolute force generated by phrenic nerve and direct muscle stimulation in the fatigue protocol in 
which direct muscle stimulation was intermittently superimposed on trains of phrenic nerve stimulation 
to assess neurotransmission failure under experimental conditions.  
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The relative contribution of neuromuscular transmission failure to diaphragm fatigue 
was estimated by assuming that the force decline during direct muscle stimulation 
reflected only the contribution of muscle fatigue, whereas the force decline during 
nerve stimulation reflected the combined contribution of both muscle fatigue and 
neuromuscular transmission failure (20; 40). Therefore, the following formula, 
proposed by Aldrich et al (1), was used to estimate NTF: % NTF = (∆N - ∆M)/(1 - 
∆M), where NTF is neuromuscular transmission failure, ∆N (normalized to initial 
nerve force) is force loss during nerve stimulation and ∆M (normalized to initial 
muscle force) is force loss during direct muscle stimulation.  
 
Effects of L-NNA and Sp-NO on neuromuscular transmission failure 
The effects of the NOS inhibitor L-NNA (Sigma, The Netherlands) and the NO donor 
Sp-NO (Calbiochem, The Netherlands) on NTF were determined during hypoxia and 
hyperoxia. A final concentration of 1 mM L-NNA was used (18; 35; 41). It has been 
shown that 0.3 mM L-NNA increases cholinergic transmission in strips of canine 
colonic circular muscle (35), and that both 1 mM and 10 mM L-NNA increase 
submaximal tetanic force of the rat diaphragm in vitro during hyperoxia, which was 
more pronounced at high concentration (8; 18). Thus, 1 mM L-NNA appears to be 
high enough to completely block NOS at the diaphragm endplate (35).  
To ascertain that the effects of L-NNA on neuromuscular transmission were 
indeed mediated by NO, similar experiments were performed with Sp-NO (1 mM). 
This concentration of Sp-NO has been shown to reduce force generation in the rat 
diaphragm in vitro after 30 min of hypoxia (47), and to reduce shortening velocity in 
permeabilized rabbit psoas muscle fibers (11). Sp-NO, a nucleophilic type of NO 
donor, is capable of generating NO in a predictable manner in aqueous buffers by a 
non-enzymatic process (14; 25). In comparison with other nucleophilic adducts, Sp-
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NO generates NO in a long lasting and a constant manner (14). These properties make 
Sp-NO an ideal vehicle for the delivery of NO in the current study. Sp-NO was 
freshly prepared for each experiment and added directly to the Krebs solution in the 
tissue bath (37). 
The effects of L-NNA and Sp-NO on neuromuscular transmission were 
assessed under hypoxic and hyperoxic conditions. Accordingly, six experimental 
groups were studied: hypoxia control (n = 9), hypoxia L-NNA (n = 8), hypoxia Sp-
NO (n = 8), hyperoxia control (n = 8), hyperoxia L-NNA (n = 8), hyperoxia Sp-NO (n 
= 8). Only one strip was obtained from each animal, thus the total number of rats used 
in present study is 49. The diaphragm bundles were randomly allocated to the 
treatment groups.  
To verify the experimental conditions, Pco2, and Po2 of the Krebs solutions in 
the tissue baths were measured after completion of contractile experiments (Ciba 
corning 238 pH/ Blood gas Analyzer). The pH was measured at regular intervals 
throughout the experimental protocol. After completion of contractile experiments, the 
length of each diaphragm strip was measured by using a micrometer, and the strips 
were weighed on an analytic balance. Cross sectional area was calculated by dividing 
diaphragm strip weight (g) by strip length (cm) times specific density (1.056). Forces 
were expressed per cross sectional area (N/cm2). 
 
Statistical Analysis 
Data are presented as mean ± SE. Differences in single baseline contractile properties, 
bundle dimensions, and gas pressure among the experimental groups were analyzed with 
one-way ANOVA and if appropriate, Student-Newman-Keuls post-hoc testing. 
Parameters requiring repeated-measures over time (e.g., the difference between forces 
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generated by nerve vs. direct muscle stimulation) were estimated by using repeated-
measures models and if appropriate, SNK post hoc testing. Statistical analysis was 
performed with the SPSS package version 10.0 (SPSS, Chicago, IL). Comparisons 
were considered significant at P < 0.05.  
 
Results 
Verification of experimental conditions, strip dimensions and quality 
Perfusion of the tissue baths with the hypoxic gas mixture reduced Po2 of the Krebs 
solution to ~ 5.8 ± 0.1 kPa, as compared with 64.0 ± 1.3 kPa in the hyperoxic groups 
(P < 0.001). The pH and Pco2 of the tissue baths were not significantly different 
between hypoxic and hyperoxic groups (pH: 7.39 ± 0.01 vs. 7.36 ± 0.01 in hypoxic 
and hyperoxic groups respectively; Pco2: 4.7 ± 0.1 kPa vs. 4.9 ± 0.1 kPa in hypoxic 
and hyperoxic groups respectively).  
Diaphragm muscle strip dimensions were not significantly different among the 
experimental groups. Average muscle strip weight was 42.3 ± 0.9 mg, and strip length 
at Lo was 20.1 ± 0.2 mm.  
 
Baseline contractile properties  
No significant differences were found for P40M and P40N at baseline among the 
experimental groups. Mean values of P40M were 25.9 ± 0.7 N/cm2 in the hypoxic 
groups and 26.2 ± 0.7 N/cm2 in the hyperoxic groups. Average baseline values of 
P40N were 20.6 ± 0.8 N/cm2 and 20.4 ± 0.7 N/cm2 in the hypoxic and hyperoxic 
groups, respectively.  
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Neuromuscular transmission failure 
HYPOXIA. Thirty minutes of hypoxia had prominent effects on force generated via 
phrenic nerve (P40N) and to a lesser extend on direct muscle stimulation (P40M). 
P40M was significantly lower in hypoxia control than in hyperoxia control (P = 
0.001). Also, P40N was significantly lower in the hypoxia control than in the 
hyperoxia control (P < 0.001, Fig 2A/B). Consequently, neurotransmission failure 
was significantly higher in hypoxia control vs. hyperoxia control (51 ± 6 % vs. 3 ± 1 
% respectively, P < 0.001, see fig 4B, 4D at time = 0 sec).  L-NNA increased P40N 
under hypoxic conditions (P < 0.001, versus hypoxia control, Fig 3A). P40M tended to 
be higher in hypoxia + L-NNA than in hypoxia control (P = 0.10, Fig 3A). Therefore, 
L-NNA reduced neurotransmission failure under hypoxic conditions (11 ± 2 % vs. 51 
± 6 % in hypoxia-L-NNA and hypoxia control respectively, P < 0.001, Fig 4B). Sp-
NO had opposite effects, i.e. it impaired both P40M and caused an even more 
pronounced reduction of P40N (Fig 3A). Therefore Sp-NO increased 
neurotransmission failure under hypoxic conditions (51 ± 6 % vs. 85 ± 8 % in hypoxia 
control and hypoxia Sp-NO respectively P < 0.01).   
HYPEROXIA. Neither L-NNA, nor Sp-NO significantly affected P40M or P40N under 
hyperoxic conditions (Fig 3B). Accordingly, L-NNA and Sp-NO did not significantly 
affect neurotransmission under hyperoxic conditions (Fig 4D, at 0 sec. P > 0.05 vs. 
hyperoxia control).  
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Figure 3.  Diaphragm submaximal tetanic force generated by direct muscle stimulation at 40 Hz 
(P40M) and via nerve stimulation at 40 Hz (P40N) after 30 min incubation in experimental Krebs 
solution. Values are expressed as percentage of baseline value. 
 A: Hypoxic conditions (Po2 ~ 5.8 kPa). L-NNA tended to increase P40M, but this did not reach 
statistical significance (P = 0.10, n = 7). Sp-NO significantly decreased P40M (P < 0.05, n = 7) 
compared to hypoxia control. P40N was significantly higher in the presence of L-NNA (P < 0.001) but 
significantly lower in the presence of Sp-NO (P < 0.01) compared to hypoxia control.  
B: Under hyperoxic conditions (Po2 ~ 64.0 kPa) neither L-NNA (n = 8) nor Sp-NO (n = 7) significantly 
altered P40M or P40N compared to hyperoxia control (n = 8) 
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Figure 4.  Development of force generated by either repetitive muscle or nerve stimulation (see 
methods). The difference in force generated by direct muscle stimulation versus nerve stimulation was 
used to estimate extent of neurotransmission failure.  
A, B Hypoxia; A, The difference between force generated by nerve and by muscle stimulation was less 
in the presence of L-NNA compared to hypoxia control (* P < 0.001). Sp-NO had detrimental effects 
on force generated via phrenic nerve stimulation, with no measurable P40N within 20 sec. B, 
Consequently, L-NNA significantly reduced NTF, especially during the early stages of fatiguing 
stimulations (* P < 0.001).  Sp-NO resulted in complete NTF with 18 sec.  
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Figure 4 C, D Hyperoxia; C, The difference between P40N and P40M progressively increased during 
repetitive stimulations, but the course was not significantly altered by either L-NNA or Sp-NO (P > 
0.05). D, However, L-NNA significantly reduced NTF under hyperoxic conditions compared to control 
(* P < 0.05). Sp-NO did not affect NTF (P > 0.05). 
As can be derived from figure 4B and 3D, hypoxia increases NTF at baseline (t = 0 sec) and during 
repetitive stimulation compared to hyperoxia control (P < 0.001, repeated measurements analysis).  
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Neurotransmission during fatiguing contractions 
HYPOXIA. Fig 4A show the relative force generated by nerve and direct muscle 
stimulation in the experimental fatigue protocol under hypoxic conditions for three 
experimental groups. Repetitive stimulation enhanced the difference between force 
generated by direct muscle and by nerve stimulation under hypoxic conditions. A 
similar pattern occurred in the presence of L-NNA, but the difference between forces 
was less pronounced, especially during the first minute (Fig 4A). Consequently, 
neurotransmission failure was significantly reduced by L-NNA (Fig 4B, P < 0.001, 
repeated measurement analysis). In contrast, Sp-NO had detrimental effects on force 
generated by nerve but not via direct muscle stimulation (Fig 4A). Consequently, 
within 20 sec almost complete neuromuscular transmission failure occurred in the 
presence of Sp-NO (P < 0.01 vs. hypoxia control, Fig 4B). 
 HYPEROXIA. The relative force generated by nerve and direct muscle 
stimulation in the fatigue experiments under hyperoxic conditions are shown in Fig 
3DEF. The difference between these forces was less pronounced during hyperoxia 
(Fig 4C) and consequently neuromuscular transmission failure was less prominent in 
hyperoxia control vs. hypoxia control (Fig 4D, P < 0.001, repeated measurement 
analysis).  
The decrement in force generated by direct muscle stimulation was faster in 
hyperoxia control than in hypoxia control. This may be surprising at the first sight but 
is the result of the design of the fatigue protocol (see discussion). L-NNA reduced 
neurotransmission failure under hyperoxic conditions during fatigue (Fig 4D, P < 0.05 
repeated measurement analysis), but the effect was less prominent than during 
hypoxia. Sp-NO did not affect neurotransmission failure under hyperoxic conditions 
(Fig 4D, P > 0.05). 
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Discussion 
The data of the present study indicate that NO, or products downstream of NO 
metabolism modulate neurotransmission of the rat diaphragm under hypoxic 
conditions. Inhibiting NOS almost completely reversed the detrimental effects of 
hypoxia on neuromuscular transmission under non-fatiguing conditions (Fig 3A). This 
supports our hypothesis, that overproduction of NO plays a prominent role in 
neurotransmission failure of the rat diaphragm during hypoxia. The effect of NOS 
inhibition on neuromuscular transmission declined towards the end of fatiguing 
contractions during hypoxia, suggesting that other factors become increasingly 
important in the decline of force generation during continuing contractile activity. 
Exogenous NO had opposite effects, i.e. enhanced the contribution of neuromuscular 
transmission failure during non-fatiguing and fatiguing contractions. Under hyperoxic 
conditions, modulation of NO did not affect neuromuscular transmission during non-
fatiguing contractions, and had only modest effects during fatiguing contractions.  
 
Hypoxia and neuromuscular transmission 
 
Hypoxia impairs diaphragm muscle force generating capacity as determined 
by direct stimulation of the muscle (12; 27; 44; 46; 48). The present study confirms 
earlier data showing that force generated by phrenic nerve stimulation is even more 
susceptible to the effects of hypoxia (5; 15). Consequently, under these conditions 
neuromuscular transmission failure considerably contributes to muscle fatigue. 
Theoretically, multiple presynaptic and postsynaptic sites may be involved in 
neuromuscular transmission failure, including reductions in axonal potential 
propagation, synaptic transmission failure and failure to generate a sarcolemmal 
potential (for review see i.e. (39)). The precise site of action for hypoxia in 
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neuromuscular transmission failure is unknown. However, in vitro experiments 
showed that anoxia inhibits nerve conduction (19). In addition, hypoxia has been 
shown to reduce end plate potential in phrenic nerve diaphragm preparation, prior to 
the block of nerve conduction (15; 32). The fall in end plate potential amplitudes is 
mostly the result of a reduction in transmitter release, although the fall in resting 
potentials also contributed to a fall in end plate potential amplitudes (15; 32).  
In the present study, the decline in force in response to direct muscle 
stimulation is faster under hyperoxic than hypoxic conditions (Fig 4A vs. 4C). This is 
explained by the fact that the extent of force decline with direct muscle stimulation is 
primarily due to the repetitive activation imposed on the muscle by nerve stimulation 
(Fig 2). Thus, neurotransmission failure will preserve force generation in response to 
direct muscle stimulation in our experimental set up. As neurotransmission failure 
was more prominent under hypoxic conditions, a lower proportion of muscle fibers 
were activated during nerve stimulation then under hyperoxic conditions. This 
explains the faster decline in force in response to direct muscle stimulation under 
hyperoxic conditions.  
 
Nitric oxide and neurotransmission during hypoxia  
Previous studies have investigated the effect of NO modulation on diaphragm 
contractility under hyperoxic and hypoxic conditions i.e. (18; 28; 47; 48). NOS 
inhibitors increase in vitro force generation of the diaphragm under both hypoxic and 
hyperoxic conditions, although the final effect strongly depends on the concentration 
of the NOS inhibitor (48). Instead, the NO donor Sp-NO impairs isometric force 
generation of the hypoxic diaphragm muscle, but does not exert any effect on 
contractility under hyperoxic conditions (Fig 3 A/B), which is in line with previous 
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observations (47; 48). The mechanisms of NO modulation of direct force generation 
are incompletely understood. However, possible actions of NO in skeletal muscle 
include impaired calcium activation of actin filaments, resulting in impaired calcium 
sensitivity (2), modulation of sarcoplasmic ryanodine receptor channel open 
probability (13; 26; 43) altered actomyosine ATPase activity (33). The present study 
is the first to show that NO modulates neurotransmission in respiratory muscle under 
hypoxic conditions. Inhibiting NOS alleviates hypoxia-induced neurotransmission 
failure of the rat diaphragm. The fact L-NNA and Sp-NO modulate neuromuscular 
transmission in opposite directions under hypoxic conditions indicate that the 
observed effects were mediated via NO or products downstream of NO metabolism. 
Since the responses of NOS inhibition are more pronounced under hypoxic 
conditions, it is likely that hypoxia enhances generation of NO at the neuromuscular 
junction. The lack of effect of NO donors on in vitro diaphragm contractility under 
hyperoxic conditions is in line with previous observations (18; 22; 29; 48), and 
suggests that diaphragm muscle fibers might be able to adjust NO concentration 
during hyperoxia. Indeed, it has been shown that NO can adjust its own synthesis by 
feedback inhibition in restricting NO production (7) As discussed previously (48) it is 
unlikely that NO released from Sp-NO was scavenged by O2 in the hyperoxic 
solutions.  
High NOS expression has been detected in the motor endplate of skeletal 
muscle of both type I and II fibers (8; 21). Interestingly, NOS activity is increased 
under hypoxic conditions in pulmonary artery endothelium (10). However, this has 
not been studied in skeletal muscle. Nevertheless, it is conceivable that with hypoxia 
NOS activity also increases in the diaphragm, resulting in elevated NO generation that 
may act as a negative feedback on neuromuscular transmission. Indeed, we have 
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recently shown that hypoxia enhances diaphragm protein nitration, indicating elevated 
generation of reactive nitrogen species (48).  
Inhibition of NOS was most effective in alleviating neurotransmission failure 
in early stages of repetitive nerve stimulation during hypoxia (Fig 4A/B), indicating 
that NO predominantly affects the early phase of fatigue and that other factors 
become more important during later phases of fatigue. The experimental set up of the 
present study does not allow identifying the specific targets for NO at the 
neuromuscular junction. However, our finding that endogenously generated NO 
inhibits the synaptic efficacy of the rat diaphragm is in line with previous 
observations (30; 45). NO has been shown to reduce non-quantal acetylcholine release 
form synaptic terminals in rat diaphragm muscle (30). Also, in frog neuromuscular 
junction, application of the NO donor sodium nitroprusside inhibited the evoked 
quantal release of acetylcholine by repetitive stimulation (23). These studies suggest 
that NO or metabolites down-stream of NO metabolism inhibit acetylcholine release 
at the neuromuscular junction. This is in line with observations by Hubbard and 
Loyning (15; 32), showing that in rat phrenic nerve-diaphragm preparation hypoxia 
reduces end plate potential amplitudes, that could be brought solely by a reduction in 
neurotransmitter release, although other mechanism may play a role as well. The 
physiological relevance of NO modulation of neuromuscular transmission remains 
unclear, but a possible hypothesis could be that NO acts as a retrograde signaling 
molecule that modulates transmitter release to protect the muscle from contraction-
induced damage, for instance during hypoxia. This is supported by the fact that in the 
present studies the effects of NOS inhibition were much more pronounced under 
hypoxic compared to hyperoxic conditions.  
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In conclusion, the present study shows that NO aggravates neuromuscular 
transmission failure in the rat diaphragm under hypoxic conditions. Inhibiting NOS 
improves contractile performance of the diaphragm. The clinical significance of this 
mechanism remains to be investigated. It could be hypothesized that 
neurotransmission failure during hypoxia is a physiological mechanism to protect the 
diaphragm from damage. Therefore, a thorough understanding of hypoxia-induced 
alterations in neuromuscular transmission is highly relevant since hypoxemia is a 
prominent feature of many respiratory diseases. 
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Summary and Conclusions 
 
Introduction 
Exercise limitation is one of the most troubling manifestations of chronic obstructive 
pulmonary disease (COPD). Both peripheral and respiratory muscle dysfunction 
significantly contribute to exercise intolerance and dyspnea in these patients. 
However, the causative factors and underlying mechanisms for respiratory muscle 
dysfunction in COPD are incompletely understood. Hypoxemia is a prominent feature 
many respiratory diseases, including COPD. Several studies have shown that hypoxia 
impairs skeletal muscle performance, although the precise mechanisms are 
incompletely understood. Evidence is emerging that hypoxia enhances generation of 
reactive oxygen species and reactive nitrogen species in skeletal- and cardiac muscle.  
Nitric oxide (NO), an endogenously generated free radical, is physiologically 
produced in skeletal muscle by nNOS and eNOS. NO modulates skeletal muscle 
function through a number of pathways, including regulation of blood flow, 
regulation of muscle glucose metabolism, Ca2+ release from the sarcoplasmic 
reticulum, direct effect on contractile properties and the defense against oxidative 
stress. NO is involved in intracellular oxygen sensing, a system that monitors tissue 
PO2, and activates a pathway that exerts influence on the transcriptional factors such 
as HIF-1α. Acute and chronic hypoxia has been shown to activate NOS activity and 
nNOS protein levels in several tissues in vitro and in vivo. It has been established that 
endogenous NO modulates contractile function of skeletal muscle in isolated muscle 
preparation under hyperoxic conditions. The aim of the present thesis was to 
investigate the role of NO on contractile performance of the rat diaphragm under 
hypoxic conditions.  
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NO impairs force generation of skeletal muscle under hyperoxic conditions, 
although he effects are concentration dependent. Hypoxia disturbs cellular Ca2+ 
regulation and increases [Ca2+]I, which may in turn activate NOS. The studies 
presented in this thesis report the effects of the NO modulation and generation on 
contractile properties of the rat diaphragm under hyperoxic and hypoxic conditions.  
Under hypoxic conditions, elevated [Ca2+]i may serve as a seconded messenger to 
activate NOS resulting in elevated NO generation and subsequently modulation of 
force generation. In Chapter 2 we studied the effects of NO modulation on isometric 
force generation of rat diaphragm muscle bundles under hypoxic (Po2 ~ 7 kPa) and 
hyperoxic (Po2 ~ 83 kPa) conditions in vitro. Muscle bundles were incubated with the 
non-specific (thus inhibiting all three isoforms) NOS inhibitor L-NMMA at different 
concentrations. Low concentration of L-NMMA improved Pt and P30, whereas high 
concentrations decreased Pt and P30. These effects were more pronounced under 
hypoxic then hyperoxic conditions. The NO scavenger hemoglobin increased 
isometric force generation of the hypoxic rat diaphragm. The NO donor Sp-NO 
reduced isometric force generation under hypoxic conditions, but did not affect the 
hyperoxic diaphragm. These data indicate that NO plays a prominent role in impaired 
force generation in the hypoxic diaphragm, but complete inhibition of NO synthesis 
also impairs contractility.   
In Chapter 3 we assessed the effects of NO on isotonic contractile and fatigue 
properties rat diaphragm during hypoxia. This is of clinical relevance because isotonic 
contractile properties better reflect diaphragm muscle performance in vivo then 
isometric contractility. Intracellular NO was modulated by adding the NOS inhibitor 
L-NMMA, the NO scavenger haemoglobin or the NO donor Sp-NO to the tissue bath 
under hypoxic and hyperoxic conditions. Both inhibition of NOS and scavenging NO, 
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slowed velocity of shortening, depressed power generation, and increased the 
fatigability of the rat diaphragm in vitro during hypoxia. Supplementation of NO, did 
not affect isotonic contractility of the diaphragm under hypoxic conditions. Together, 
these findings indicate that NO plays a protective role in cross-bridge cycling under 
hypoxic conditions.  
Previous studies have shown that NO modulates force generation of the hypoxic 
diaphragm. However, as hypoxia also enhances generation of superoxide, it is likely 
that hypoxia increases formation of peroxynitrite, the reaction product of NO and 
superoxide. As peroxynitrite is an extremely reactive molecule and it has been shown 
to modulate force generation in skeletal muscle, studying peroxynitrite formation 
under hypoxic conditions is of potential physiological relevance (chapter 4). Protein 
nitration was used as a marker for peroxynitrite formation. The effect of hypoxia on 
rat diaphragm protein nitration was assessed. Also, we studied the effect of NOS 
inhibition, peroxynitrite scavenging, authentic peroxynitrite and strenuous 
contractions on protein nitration of the hypoxic diaphragm. This study shows that 
hypoxia increases rat diaphragm nitrotyrosine formation, indicating elevated 
peroxynitrite formation under hypoxic conditions. Moreover, inhibiting NOS in het 
rat diaphragm reduces hypoxia-induced protein nitration and improves diaphragm 
contractility under hypoxic conditions. Subsequent experiments showed that 
incubating hyperoxic diaphragm muscle with authentic peroxynitrite enhances protein 
nitration and reduces force generation. In line with these observations, fatiguing 
contractions of the diaphragm under hyperoxic conditions were associated with 
enhanced protein nitration. Together, these data support a role for protein nitration in 
diaphragm contractility under hypoxic conditions, although a causal relationship has 
not been proven. This adds to the accumulating evidence that protein nitration is 
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involved in posttranslational signalling by altering protein function, in this case under 
hypoxic conditions. Further studies are needed to confirm a causal relationship 
between protein nitration and diaphragm contractility.  
Hypoxia accelerates diaphragm muscle fatigue in vivo, which could be the result of a 
failure of the muscle tissue itself to generate force (contractile fatigue) and/or a failure 
in neuromuscular transmission (NTF). nNOS is present in high concentrations at the 
post-synaptic surface of the neuromuscular junction of fast- and slow- twitch fibers 
and NO has been identified as a neurotransmitter in the central and peripheral nervous 
system. In chapter 5 the effects of NO modulation on neurotransmission in a phrenic 
nerve-diaphragm preparation under hypoxic and hyperoxic conditions were studied. 
We tested the hypothesis that NO involves in the hypoxia-induced NTF of the rat 
diaphragm in vitro. The effects of the NOS inhibitor L-NNA and the NO donor Sp-
NO on rat diaphragm neuromuscular transmission were evaluated during non-
fatiguing and fatiguing contractions under hypoxic conditions. The relative 
contribution of NTF to diaphragm fatigue was estimated by assuming that the force 
decline during direct muscle stimulation reflected only the contribution of muscle 
fatigue, whereas the force decline during nerve stimulation reflected the combined 
contribution of both muscle fatigue and NTF. Hypoxia increased NTF during both 
non- fatiguing and fatiguing stimulation of the rat diaphragm. This effect was 
alleviated by L-NNA and aggravated by Sp-NO. This indicates that NO plays a role in 
the hypoxia-induced NTF. The effect of L-NNA on NTF declined towards the end of 
fatiguing contractions during hypoxia, suggesting that other factors become 
increasingly important in the late stage. Under hyperoxic conditions, NOS inhibition 
only slightly reduced NTF during fatiguing contractions.  
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In conclusion, the studies presented in this thesis indicate that NO plays a role in 
rat diaphragm contractility under hypoxic conditions, but the final effect is complex. 
Inhibiting NOS improves isometric contractile properties of the diaphragm but 
reduces velocity of shortening under hypoxic conditions. Moreover, NO also plays a 
role in neuromuscular transmission of the diaphragm. NO appears to enhance 
neurotransmission failure under hypoxic conditions. NO may be involved in many 
biochemical pathways in vivo. Hypoxia enhanced protein nitration in the diaphragm, 
which was sensitive to the effects of NOS inhibition and exposure to peroxynitrite. 
This indicates that at least part of the effects of NO on muscle contractility was 
mediated via peroxynitrite.  
 
Future directions 
NO has been the subject of numerous studies in recent years. It appears that NO is 
involved in numerous physiological pathways in skeletal muscle, and other tissues as 
well. The studies presented in this thesis are the first to describe a role for NO in force 
modulation under hypoxic conditions. However, the nature of these experiments is 
mostly descriptive and a causal relationship for NO in force modulation needs to be 
confirmed, including the specific targets for NO in skeletal muscle.  
 In addition, future research should be directed at the evaluation of clinical 
significance of findings presented in this thesis. Hypoxia impairs skeletal muscle 
function in vivo, but underlying mechanisms are incompletely understood. It should 
be evaluated that acute hypoxia enhances NO generation and more specifically 
protein nitration of the diaphragm in vivo. Moreover, a relationship with contractile 
performance should be established. It could be hypothesized that NO plays a role in 
cute hypoxic respiratory failure, for instance ion severe pneumonia. The effect on 
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NOS inhibition on respiratory muscle function in acute hypoxemic patients is an 
interesting subject for future research and of probable clinical interest.  
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